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INTRODUCTION 
 
 Currently  variety of non operative therapies for back and leg pain 
are available. They are simple rest, exercises, massage, heat therapy, 
traction therapy.  
 
  “Epidural steroid injections (ESIs) have been used as an adjunct in 
the treatment of sciatica. Since the early reports, success rates ranging 
from 18% to 90% (average, 67%) have been documented.  However, the 
efficacy of ESI has lasted, on the average, less than 3months.”38 
 
 In recent years, understanding of disc degeneration has undergone 
a significant transformation. Impairments of the back and spine are 
ranked as the most frequent cause of limitation of activity in individuals 
younger than 45 years old by the National Center for Health Statistics.1 
 
 Epidural injections in the cervical, thoracic, and lumbosacral spine 
were developed to diagnose and treat spinal pain. Structural abnormalities 
do not always  cause pain, and diagnostic injections can help to correlate 
abnormalities seen on   imaging studies with associated pain complaints. 
In addition, epidural injections can provide pain relief during the recovery 
of disc or nerve root injuries and allow patients to increase their level of 
physical activity. Because severe pain from an acute disc injury with or 
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without radiculopathy often is time limited, therapeutic injections help to 
manage pain and may alleviate or decrease the need for oral analgesics. 
 
 Epidural steroids are given by orthopaedicains, anesthetists,  
radiologists. Recent studies indicate that a high percentage of patients 
receiving the injections have significant pain relief and functional 
improvement.   In a group of 70 patients with herniated  discs in whom 
other conservative management had failed,  epidural steroid injections 
provided significant pain relief and avoided surgery in  64% .Better 
outcomes were noted in patients older than 48 years and those who  
received the injections earlier (<100 days from diagnosis). 
 
 Few serious complications occur in patients receiving epidural 
corticosteroid injections; however, epidural abscess, epidural hematoma, 
durocutaneous fistula, and Cushing syndrome have been reported as 
individual case reports. The most adverse immediate reaction during an 
epidural injection is a vasovagal reaction. Dural puncture has been 
estimated to occur in 0.5% to 5% of patients having cervical or lumbar 
epidural steroid injections. The anesthesiology literature reported a 7.5% 
to 75% incidence of postdural puncture (positional) headaches, with the 
highest estimates associated with the use of 16- and 18-gauge needles. 
Headache without dural puncture has been estimated to occur in 2% of 
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patients and is attributed to air injected into the epidural space, increased 
intrathecal pressure from fluid around the dural sac, and possibly an 
undetected dural puncture. Some minor, common complaints caused by 
corticosteroid injected into the epidural space include non-positional 
headaches, facial flushing, insomnia, low-grade fever, and transient 
increased back or lower extremity pain. 
 
 Epidural corticosteroid injections are contraindicated in the 
presence of infection at the injection site, systemic infection, bleeding 
diathesis, uncontrolled diabetes mellitus, and congestive heart failure. 
Epidural corticosteroid injections are performed in a fluoroscopy suite 
equipped with resuscitative and monitoring equipment.  
 
 It is recommended the use of fluoroscopy for diagnostic and 
therapeutic epidural injections for several reasons. Epidural injections 
performed without fluoroscopic guidance are not always made into the 
epidural space or the intended interspace. 
 
 Even in experienced hands, needle misplacement occurs in 40% of 
caudal and 30% of lumbar epidural injections when done without 
fluoroscopic guidance. Accidental intravascular injections also can occur, 
and the absence of blood return with needle aspiration before injection is 
an unreliable indicator of this complication. In the presence of anatomical 
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anomalies, such as a midline epidural septum or multiple separate 
epidural compartments, the desired flow of epidural injectants to the 
presumed pain generator is restricted and remains undetected without 
fluoroscopy. In addition, if an injection fails to relieve pain, it would be 
impossible without fluoroscopy to determine whether the failure was 
caused by a genuine poor response or by improper needle placement. 
  
Review of Literature 
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REVIEW OF LITERATURE 
 
 
 Studies done two decades back did not reliably establish the 
efficacy of epidural injections, because of the lack of well-controlled 
studies.  
 
           Riew et al21 conducted a “prospective, randomized, controlled, 
double-blind study in: proceedings of the North American Spine 
Society, 14th Annual Meeting in 1999”  showed early promising results 
of  transforaminal steroid injection (TFESI) in lumbar canal stenosis. 
 
              Only in 2013 North American Spine Society (NASS) forms a 
work group to address following issues - efficacy of lumbar 
transforaminal steroid injection (LTFESI)  in radicular pain and lumbar 
disc herniation, complications of transforaminal steroid , patients  likely 
to benefit from lumbar transforaminal epidural steroid injections 
(LTFESI), reasonable maximum number of therapeutic lumbar TFESI 
that a patient should receive within a six month period to treat lumbar 
radicular pain, the value (eg, cost per Quality Adjusted Life Years) of 
TFESI in the treatment of lumbar radicular pain.   
 
 Hospital For Special Surgery- Spine unit in their study in 2002 of 
“Transforaminal    Epidural   Steroid Injections in Lumbosacral 
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Radiculopathy,38 conducted a prospective RCT to assess the efficacy of 
LTFESI in patients with lumbar radiculopathy secondary to herniated 
intervertebral disc (HIVD). Of the 50 consecutively assigned  patients, 25 
received LTFESI and 25 received paravertebral trigger point injections.  
After an average follow-up period of 16 months, the group receiving 
LTFESI had a success rate of 84% as compared to 48% of the group 
receiving trigger-point injections. This study provides therapeutic 
evidence that for patients with herniated intervertebral disc (HIVD), 
LTFESI is more often effective (84%) than trigger point injections (48%) 
in providing at least 50% relief of radicular pain at 16 months”. 
 
 A retrospective study comparing Interlaminar epidural steroids 
(ILESI) to Transforaminal epidural injections (TFESI) for symptomatic 
lumbar intervertebral disc herniations found that transforaminal injections 
resulted  in better short-term pain improvement and fewer long-term 
operative interventions. 
 
 More recently, a number of randomized, double-blind, controlled 
studies have been done to evaluate the effectiveness of both cervical and 
lumbar interlaminar injections, as well as caudal epidural injections in the 
treatment of chronic discogenic pain with and without radiculitis. Overall 
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these studies indicate that a high percentage of patients receiving the 
injections have significant pain relief and functional improvement.   
 
 According to Campbell - In a group of 70 patients with herniated 
cervical discs without myelopathy   in whom conservative management 
had failed, cervical epidural steroid injections   provided significant pain 
relief and avoided surgery in 63%.  
 
 North American Spine Society (NASS) states “patients with 
lumbar scoliotic stenosis and radiculopathy experience significantly 
higher success rates after LTFESI if their symptoms were present for less 
than three months.” 
 
 North American Spine Society (NASS) also states   that “in 
patients treated with TFESI in the setting of disc herniation, effectiveness 
was more likely if the disc herniation was “contained” or abutted the 
nerve root and less likely if the nerve root was displaced or entrapped. 
The presence of stenosis, size of herniated intervertebral disc (HIVD), 
type of HIVD and hydration of HIVD do not predict outcome with 
LTFESI.” 
 
 Studies have suggested the superiority of Transforaminal epidural 
steroids for both short and long-term outcomes.  
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 A retrospective study by Schaufele et al30 conducted in year 2006 
assessing pain improvement and surgical rates for managing lumbar disc 
herniation between IL and TF injection over 18 months, reported TF 
ESI’s superiority in short-term pain improvement and avoiding surgical 
interventions for long term.  
 
 Similarly   Ackerman and Ahmad in 2007, “comparing efficacy of 
3 fluoroscopically guided approaches (TF, IL, and caudal ESI) in   their 
study demonstrated superior effect of  transforaminal method of 
delivery.”31 
 
 An advantage of TFESI is that it can be performed in patients with 
failed back disease. 
 
 NASS (North American Spine Society) also states “patients with 
radicular pain from an HIVD or central stenosis and/or lateral recess 
stenosis at the supra-adajacent intervertebral disc, obtain significant relief 
from a preganglionic LTFESI irrespective of age, gender, level of 
injection, symptom duration and pain intensity.” 
 
 Gharbo et al32 conducted a randomized, blinded, prospective 
outcome study which showed better results for ILESI may be due to 
midline Para median approach instead of traditional midline approach. 
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 Traditional Interlaminar epidural steroids routinely given by 
anesthetists. But transforaminal approach commonly practiced by 
orthopedic surgeons and some well trained anesthetists, shows clear cut 
long    term benefit also avoids surgical intervention.  
 
Table 1 A : Head-to-head studies comparing  TFESI vs. ILESI. 
AUTHOR YEAR OUTCOME 
Bogduk et al2 1999 supported usefulness of TFESI for disc prolapse 
Riew et al21 1999-spine society meeting 
Early promising results using 
TFESI in the treatment of 
lumbar spinal stenosis 
Buenaventura RM, 
Datta S, Abdi S, 
Smith HS33 
2009 TFESI superior than ILESI 
Schaufele et al30 2006 TFESI superior than ILESI 
Parr AT, Diwan S, 
Abdi24 2009 TFESI superior than ILESI 
Rados et al 39 2011 TFESI superior than ILESI 
 
 Bogduk et al2   study in year 1999 supported usefulness of TFESI 
for disc prolapse. 
  
  Buenaventura RM et al33, Schaufele et al, PARR et al  
demonstrated  better  outcome of Transforaminal steroids as they deliver 
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steroid directly over the inflamed nerve.  Rados I, Sakic K, Fingler M et 
al, in their study in year  2011   at the end of 6 months found 28.3% in 
TFESI and 25% in ILESI as functional improvement. 
 
 However, some   of the articles   showing ILESI producing better 
results than TFESI.  Such studies are,  
 
Table 1B: Head-to-head studies comparing TFESI vs. ILESI 
 
 
 YEAR 
Functional Improvement 
TFESI vs. ILESI 
Gharbo et al 36 2011 43.6% vs. 49.3% 
Kolsi et al35 JBJS 2000 34.8% vs. 50.9% 
Ackerman and Ahmad 37 2007 53.3 vs 60.6 
 
 Gharbo et al36    study in year 2011, total duration of study was only 
16 days. 
 
 Kolsi et al35 in their study of “Efficacy of nerve root versus 
interspinous injections    of glucocorticoids in the treatment of disk 
related sciatica. A pilot, prospective, randomized, double-blind study, 
Joint Bone Spine 2000’   is also short duration    study of only 28 days. 
Also participants were only 17 and 13in TFESI and ILESI respectively.             
 
  
Aim of Study 
  
11 
 
 
 
 
AIM OF STUDY 
 
 To compare efficacy of pain relief function of therapeutic 
transforaminal vs interlaminar epidural steroid injections for 
symptomatic   lumbar disc disease patients. 
 
 To assess improvement in functional outcome in lumbar disc disease 
patents after treatment  
 
 To evaluate duration of relief and long term outcome after epidural 
steroid injections. 
 
 To assess the quality of improvement in pain relief. 
 
 To assess patient satisfaction   after steroid injection. 
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RELEVANT ANATOMY 
 
 The human spinal column is an articulated segmental structure that 
serves dual purposes of protection and motion.  The spinal columns  
functions include maintaining an upright posture, yet allowing for 
flexibility, while at the same time providing a conduit for neurological 
structures.   
 
OSTEOLOGY:  
LUMBAR SPINE 
 It consists of 5 vertebrae, which resemble each other structurally. 
The size gradually increases from L1 to L5. It consists of osseous and 
ligamentous structures 
 
 The block of bone on anterior part called vertebral body consists of 
compact mass of spongy bone surrounded by cortical bone. Vertebral 
bodies and the intervening discs, along with anterior and posterior 
longitudinal ligaments constitute the anterior and middle column of 
Denis. This bears 80 % of load in upright position. 
 
 A typical vertebra is composed of an anterior cancellous vertebral 
body and a posterior vertebral arch. The vertebral arch consists of a pair 
of cylindrical pedicles which form the sides of the arch, and a pair of 
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flattened laminae which completes the arch posteriorly. The articular 
processes are vertically arranged and consist of two superior and two 
inferior processes.   
 
 
 
THE VERTEBRAL CANAL:   
Boundaries 
 Anterior wall- Posterior longitudinal ligament, posterior                                                
surface of lumbar vertebrae 
 Posterior wall - Lamina, Ligamentum flavum 
 Lateral wall- pedicle 
 Between the pedicles of adjacent vertebrae, lies the intervertebral 
foramen. 
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INTERVERTEBRAL FORAMEN:  
 The vertebral notches are located on the superior and inferior 
aspects of the pedicles of all vertebrae. The inferior vertebral notch is the 
most prominent and together with the superior vertebral notch of the 
vertebra below forms an intervertebral foramen, which are the exit points 
for the spinal nerves that leave the vertebra. 
 
 
THE INTERVERTEBRAL DISCS:    
 It consists of nucleus pulposus and annulus fibrosus. The fibrosus 
part is made of fibro cartilage, arranged in concentric circles. Nucleus 
pulposus is composed of loose, non-oriented collagen fibroid framework, 
supporting a network of cells resembling fibrocytes and chondrocytes. 
They are embedded in a gelatinous matrix of glycosaminoglycans and 
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water. The intervertebral discs make up approximately 25 percent of the 
total length of the vertebral column above the sacrum. In the lumbar 
region, the disc material makes up 33 percent of the length of the column.  
 
 At birth, the disc has some direct blood supply contained within the 
cartilaginous endplates and the annulus. These vessels recede in the first 
years of life, and by adulthood there is no appreciable blood supply to the 
disc. Over time, for reasons not well understood, the water content of the 
gelatinous nucleus matrix decreases, with a decreased and altered 
proteoglycan composition. These changes lead to a more fibrous 
consistency of the nucleus, which ultimately fissures. Blood vessels grow 
into the disc through these outer fissures, with an increase in cellular 
proliferation and formation of cell clusters. Also, there is an increase in 
cell death, the mechanism of which is unknown. The cartilage endplates 
become thinned, with fissuring occurring with subsequent sclerosis of the 
subchondral endplates. Herniated discs have a greater number of 
senescent cells than non-herniated discs and have higher concentrations 
of matrix metalloproteinases. 
 
 The normal adult disc has a large amount of extracellular matrix 
and a few cells that account for about 1% by volume. These cells are of 
two phenotypes: annulus cells and nucleus cells. The annulus cells are 
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more elongated and appear more like fibroblasts, whereas nucleus cells 
are oval and resemble chondrocytes. These two cell types behave 
differently and may be able to sense mechanical stresses. In culture, they 
respond differently to loads and produce different matrix proteins. The 
annulus cells produce predominantly type I collagen, whereas nucleus 
cells synthesize type II collagen. The characteristics of these cell types 
under normal and abnormal circumstances are beginning to be 
determined, and much is known.  
 
 The cells within the disc are sustained by diffusion of nutrients into 
the disc through the porous central concavity of the vertebral endplate. 
Histological studies have shown regions where the marrow spaces are in 
direct contact with the cartilage and that the central portion of the 
endplate is permeable to dye. Motion and weight bearing are believed to 
be helpful in maintaining this diffusion. The metabolic turnover of the 
disc is relatively high when its avascularity is considered but slow 
compared with other tissues. The glycosaminoglycan turnover in the disc 
is quite slow, requiring 500 days. 
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Farfan H has shown that lumbar disc herniation may be reflective 
of high stresses at the posterolateral region of the disc secondary to 
torsion. Also the posterior longitudinal ligament is very weak in the 
posterolateral aspect. These high loads and weakened posterior 
longitudinal ligament cause fatigue failure of the annulus fibrosus that 
enables the inner nucleus pulposus to penetrate the laminations of the 
annulus gradually until a herniation occurs. Because the region of the disc 
with the highest torsional stresses is adjacent to the nerve root, these 
posterolateral herniations nearly always affect the exiting root or the 
central thecal sac. Less commonly, the disc may protrude into the 
extraforaminal area and produce compromise of the more proximal 
exiting root.   
 
18 
 
 
 
BLOOD SUPPLY:  
 Paired lumbar arteries arise directly from the posterior aspect of the 
aorta, in front of the bodies of the lumbar vertebrae. During the adult 
phase of life, there is no active blood supply to the intervertebral discs. 
The vasculature of the nerve roots is formed by branches from the 
intermediate branch of the segmental artery distally and by branches from 
the vasa corona of the spinal cord proximally. The venous supply of the 
lumbar spine mirrors the arterial supply.  The venous system is valveless, 
draining the internal and external venous system into the inferior vena 
cava .    
 
NERVE SUPPLY:  
 The sinuvertebral nerve, arising from its corresponding spinal 
nerve, innervates the posterior longitudinal ligament, the superficial layer 
of the annulus fibrosus, the blood vessels of the epidural space, the 
anterior dura matter, the dural sleeve surrounding the spinal nerve roots 
and the posterior vertebral periosteum.    
 
 
 
 
  
 
 
 Figure 7:Ligaments Of Lumbo Sacral Spine 
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LUMBAR DISC DISAESE 
          One theory of spinal degeneration assumes that all spines 
degenerate and   that current methods of treatment are for symptomatic 
relief, not for a cure.   
 The degenerative process has been divided into three separate 
stages with relatively distinct findings.  
 The first stage is dysfunction, which is seen in individuals 15 to 45 
years old. 
 It is characterized by circumferential and radial tears in the disc 
anulus and localized synovitis of the facet joints.  
 The next stage is instability. This stage, found in 35- to 70-year-old 
patients, is characterized by internal disruption of the disc, progressive 
disc resorption, degeneration of the facet joints with capsular laxity, 
subluxation, and joint erosion.  
 The final stage, present in patients older than 60 years, is 
stabilization.  In this stage, the progressive development of hypertrophic 
bone around the disc and facet joints leads to segmental stiffening or 
frank ankylosis. 
 Each spinal segment degenerates at a different rate. As one level is 
in the dysfunction stage, another may be entering the stabilization stage. 
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Disc herniation in this scheme is considered a complication of disc 
degeneration in the dysfunction and instability stages.  
 Spinal stenosis from degenerative arthritis in this scheme is a 
complication of bony overgrowth compromising neural tissue in the late 
instability and early stabilization stages. 
 
 Long-term follow-up studies of lumbar disc herniations have 
documented several principles, the foremost being that generally 
symptomatic lumbar disc herniation (which is only one of the 
consequences of disc degeneration) has a favorable outcome in most 
patients.  
 
 The primary benefit of surgery has been noted to occur early on in 
the first year after surgery, but with time the statistical significance of the 
improvement appears to be lost.  
 
 In general, the literature supports an active care approach, 
minimizing centrally acting medications. The judicious use of epidural 
steroids also is supported.  
 
 Non progressive neurological deficits (except cauda equina 
syndrome) can be treated non operatively with expected improvement 
clinically.  
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 If surgery is necessary, it usually can be delayed 6 to 12 weeks to 
allow adequate opportunity for improvement. These principles are 
consistent with clinical findings and treatment practices at this clinic.  
Some patients are best treated surgically. 
 
 Similar principles are valid regarding cervical disc herniations, 
which also generally can be treated non operatively. The important 
exception is a patient with cervical myelopathy, who is best treated 
surgically.  
 
 The natural history of degenerative disc disease is one of recurrent 
episodes of pain followed by periods of significant or complete relief. 
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PATHOANATOMY OF INTERVERTEBRAL DISC PROLAPSE:  
 Weber expressed that, “disc herniation is a collective term, to 
describe a process with rupture of annulus fibrosus and subsequent 
displacement of the central mass of the disc into the intervertebral space, 
common to the dorsal or dorsolateral aspect of the disc. A herniation 
occurs in a lumbar intervertebral disc when a separate tissue fragment 
extrudes or sequestrates, through a tear of the annulus.  Both a fissure and 
fragment appears to be required for prolapse to occur.” 
 
A  B  
C  D  
FIG 9; Types of disc herniation. 
A, Normal bulge, B. Protrusion,  C, Extrusion.      D, Sequestration. 
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Sensory Symptoms:  
 The sensory symptoms appear with far more frequency than the 
motor symptoms. The most common symptom, following nerve irritation, 
is pain, in the form of paraesthesia, hyperesthesia.  
 
Motor Symptoms:  
 During the initial stage of sciatica, patients are most concerned 
about sensory dysfunction and may not even notice motor deficits. 
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Infrequently, the patient may present with lower extremity weakness 
which may be disabling. This is more likely to occur in disc lesions 
involving the fourth and fifth lumbar spinal nerve roots.   
 
PHYSICAL EXAMINATION:  
 O’Connell classified the signs, in lumbar disc herniation as the 
spinal signs, nerve tension signs and neurological signs.   
 
SPINAL SIGNS:  
 Loss of normal lumbar lordosis and paravertebral spasm are 
usually seen during the acute phase of disease. Occasionally in less acute 
situation the protective muscle spasm may be elicited only when the 
patient is stressed by prolonged standing or by forward flexion of the 
spine.   
 
 In acute disc prolapse the patient usually will have a list of the 
spine which has been termed as sciatic scoliosis. When the disc is 
herniated lateral to the nerve root, the patient will list away from the side 
of the irritated nerve in an attempt to draw the nerve root away from the 
disc fragments. When the herniation is medial to the nerve root, the 
patient may list towards the side of the lesion in an effort to decompress 
the nerve root. Limitation of spine motion is usually noted during the 
symptomatic phase of lumbar disc disease, particularly prominent in the 
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sagittal plane than in the frontal plane. Palpation of the patient either in 
erect or prone position, may evoke tenderness in the midline, at the level 
of the disc lesion and in Para vertebral areas on the side of a nuclear 
extrusion.     
 
NERVE TENSION SIGNS:  
 Nerve irritation may be elicited by methods which increase the 
tension on the nerve root.   
 
The straight leg raising test:  
 The passive straight leg raising test is the most commonly 
employed one.  With the straight leg raising manoeuvre, the L5 and S1 
nerve roots, move 2 to 6mm at the level of the foramina. In an analysis of 
the diagnosis of the straight leg raising test, it was noted that tension is 
realized within the nerve roots contributing to the sciatic nerve, at 35 to 
70 degrees of elevation from the supine position.  This test is performed 
with the patient supine and head flat or on a low pillow.  Only when leg 
pain or reproduction of the patient’s radicular pain occurs, the test is 
considered positive.     
 
Well Leg Raising Test:    
 Patient lying supine, the unaffected limb is flexed at hip with knee 
in full extension. If patient develops pain along the sciatic nerve 
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distribution on the affected side, it is highly suggestive of disc prolapse 
compressing the exiting nerve root.   
 
Bow String test:   
 Patient is asked to flex the hip with knee in full extension on the 
affected side till the pain is felt. At this point, the knee is flexed which 
instantaneously reduces the pain. On pressing the sciatic nerve in the 
popliteal fossa the painful radicular symptoms restarts which indicates 
tension on the nerve roots.   
 
Sciatic nerve stretch test:   
 Patient is asked to lie supine and the foot is supported and 
gradually flexed at hip with knee in full extension; during this manoeuvre 
patient develops pain. When patient develops pain, flexion at hip is 
stopped, pressure is applied over the anterior aspect of ipsilateral knee in 
order to extend the knee. If there is sharp radicular pain, it indicates 
tension on the nerve root.   
 
NEUROLOGIC SIGNS:  
 A meticulous neurological examination often, but not always, 
yields objective evidence of nerve root compression.  It suggests the level 
of disc herniation but is not conclusive in this regard.  The involved nerve 
root usually is not completely involved and the neurologic findings may 
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vary.  There may be no objective neurologic findings because the 
involved nerve often remains functional.   Loss of Deep tendon reflex, 
motor weakness, muscle atrophy or sensory loss will be more suggestive 
of root compression. The neurological findings in the lumbosacral nerve 
root lesions are compiled in the following table. 
 
Table 2 : Table showing the Clinical Root Syndrome 
Clinical 
Root 
Syndrome 
Sensory Findings Motor Findings Deep tendon Reflex 
L4 
Numbness over the 
anteromedial thigh and 
knee 
Weakness and 
Atrophy of quadriceps. 
Knee jerk 
absent. 
L5 Numbness over lateral leg, web of great toe. 
Weakness of 
dorsiflexion of great toe and 
foot. 
Usually none. 
S1 
Numbness over back of 
calf, lateral heel, foot 
and toe. 
Weakness of plantar flexion 
of foot and great toe may be 
affected. 
Ankle jerk 
diminished or 
absent. 
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INVESTIGATIONS     
X RAY LUMBO SACRAL SPINE:   
 The first line of investigations includes X-rays of lumbosacral 
spine in both anteroposterior and lateral views. There may be loss of 
lumbar lordosis with scoliosis depending on the location of disc prolapse 
and uniform reduction of disc space. In acute IVDP there may not be 
significant reduction in intervertebral disc space. Oblique views and 
flexion extension views should be taken to rule out instability of spine   
 
MYELOGRAPHY:  
 In the past, the gold standard in the diagnosis of disc herniation had 
been the Myelogram.  Bell and associates reported the largest series 
comparing Computed Tomography with Metrizamide  Myelography in 
the diagnosis of surgically proven herniated discs and spinal stenosis. 
Albeck and associates in a controlled comparison of Myelography, CT 
and MRI in clinically suspected lumbar disc herniation indicated that CT 
or MRI should be the first choice of imaging in patients with suspected 
lumbar disc herniation.    
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COMPUTED TOMOGRAPHY (CT):   
 Major advantages of computed tomography over myelography are 
their ability to visualize the pathology, non-invasiveness and less 
radiation exposure for patients and radiologists. The importance of 
correlating, findings in the various imaging modalities with clinical 
symptoms has been emphasized in several studies.  Wiesel and associates 
performed lumbar CT Scans in 52 asymptomatic subjects.  The overall 
incidence of CT abnormalities was 37% and was more common in 
persons over 40 years of age.  
 
MAGNETIC RESONANCE IMAGING (MRI):  
 Magnetic resonance imaging offers increased soft tissue resolution 
and allow for evaluation of lateral recess pathology, in addition to 
visualizing the thoraco lumbar region for possible spinal tumours.   
ModicM.T and co-workers 35 in 1986 investigated the accuracy of MRI, 
Metrizamide  Myelography and CT in lumbar disc disease.  Their studies 
showed that MRI was more accurate than MM (82.3% vs. 71.4%) and 
was equal to CT (82.3% vs. 83%) in diagnosis of disc herniation. They 
concluded that the combination of MRI and CT was equal in diagnostic 
accuracy to the combination of CT and MM (92.5% vs. 89.4%).  
However, because MRI is non-invasive without any radiation hazard and 
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has increased soft tissue delineation its advantage to the patient as well as 
the operating surgeon is obvious. 
 
 Boden and colleagues performed lumbosacral MRI scans on 67 
asymptomatic subjects. They reported findings suggestive compressive 
pathology in approximately one third of the subjects studied.  These 
reports emphasize the need for correlation of neuro radiologic findings 
with clinical symptoms and signs and this is the first step in avoiding 
surgical complication and failed back surgery syndrome. 
  
Figure 13 B: (Case no: 19) Showing T2 sagittal L5-S1 herniation 
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MANAGEMENT 
 
1. NONOPERATIVE TREATMENT 
2. OPERATIVE TREATMENT 
 
1) NONOPERATIVE TREATMENT 
I.  CONSERVATIVE TREATMENT: 
 Currently variety of non-operative therapies for back and leg pain 
are available. They are are simple rest, massage, heat therapy, traction 
therapy. These sort of therapies are reported as producing “ miraculous 
cures”. But adequate scientific proof for these sort of therapies are very 
few. 
 
 Patients with early lumbar disc herniation benefit from 
conservative treatment. Patients with a definite diagnosis of ruptured 
lumbar intervertebral disc and sciatica, with neurological signs and 
symptoms should be carefully observed can be treated by non-surgical 
means for a period of 4-8 weeks, unless there is progressive loss of 
motor, sensory bladder or bowel function before the diagnosis. “Weber, 
Holme and Amlie reported that 70% of patients with sciatica had a 
considerable reduction in pain within four weeks”. The conservative 
treatment of lumbar disc herniation consists of bed rest and traction, 
medications, physiotherapy.   
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A. BED REST AND TRACTION:  
 The simplest treatment for acute back pain is rest.  Pain relief is 
usually experienced by a patient confined to bed.  The optimal position is 
supine with knees and hips flexed.  
 
B. MEDICATIONS:  
 Drug therapy may be directed to reduce nerve root inflammation, 
pain and for muscle relaxation. The sciatic pain is due to a perineural 
inflammatory response to the herniated disc material.  In many instances 
this inflammatory change is decreased by anti-inflammatory drugs. Bed 
rest remains the best way to treat muscle spasm. Anti-depressants reduce 
the need for analgesics in patients with chronic pain. 
 
C.PHYSIOTHERAPY:  
 Several physical agents are used for the therapeutic management of 
low back pain, out of these the most important are Short Wave 
Diathermy(SWD), Interferential Therapy (IFT), and Transcutaneous  
Electric Nerve Stimulation (TENS) . SWD are high frequency current 
commonly used at 27.12 MHz. It generates deep heat without any 
discomfort and increases local blood flow, thereby washes away the 
metabolic end products and brings about resolution of inflammation. 
 
33 
 
 
 IFT is a method of producing low frequency alternating currents 
around 4000 Hertz. Direct stimulation by interference current produces 
inhibition of sympathetic system resulting in vasodilatation and helps in 
removal of pain metabolites and exudates if present. It also reduces pain 
based on “gate theory of Melzack and Wall.”   
 
 TENS is the application of pulsed rectangular wave current forms 
through surface electrodes on the skin. It works on the principle of the 
pain gate theory and achieves pain relief by stimulating large afferent 
fibres preferentially, thus inhibiting transmission of pain impulses.  
 
II. EPIDURAL STEROID INFILTRATION : 
 The epidural injection of a combination of a long acting steroid 
with an epidural anaesthetic is directed to reduce the inflammatory 
component of disc herniation. 60-70 percent of satisfactory results have 
been described in literature. Low pressure headaches, sciatic pain 
reproduced during injection and a transitory motor weakness lasting 15-
20 minutes are some of the associated complications.   
 
 III. SURGICAL MANAGEMENT:  
 When conservative treatment fails for lumbar disc herniation, the 
next consideration is surgical treatment and the options are as follows.  
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1. Chemonucleolysis 
2. Standard laminectomy and discectomy  
3. Microscope assisted lumbar discectomy  
4. Percutaneous Discectomy  
5. Discectomy and  Spinal  Fusion  
6. Total Disc Replacement    
 
INJECTION STUDIES 
 Whenever a diagnosis is in doubt, and the complaints seem real or 
the pathological condition is diffuse, identification of the source of pain is 
problematic. The use of local anesthetics or contrast media in various 
specific anatomical areas can be helpful. These agents are relatively 
simple, safe, and minimally painful.   
 
 Contrast media such as diatrizoate meglumine (Hypaque),  
iothalamate Meglumine (Conray),  iopamidol, Iohexol (Omnipaque),  and 
metrizamide (Amipaque) have been used for discography and nerve 
blocks with no reported ill effects. Reports of neurological complications 
with contrast media used for discography and subsequent chymopapain 
injection are well documented.  
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 The best choice of a contrast medium for documenting structures 
outside the subarachnoid space is an absorbable medium with low 
reactivity because it might be injected inadvertently into the subarachnoid 
space. Iohexol and metrizamide are the least reactive, most widely 
accepted, and best tolerated of the currently available contrast media.  
 
 Local anesthetics, such as lignocaine (Xylocaine), tetracaine  and 
bupivacaine  are used frequently epidurally and intradurally. 
 
 The use of bupivacaine should be limited to low concentrations and 
low volumes because of reports of death after epidural anesthesia using 
concentrations of 0.75% or higher. 
 
 Steroids prepared for intramuscular injection also have been used 
frequently in the epidural space with few and usually transient 
complications. Spinal arachnoiditis in past years was associated with the 
use of epidural methylprednisolone acetate (Depo-Medrol). This 
complication was thought to be caused by the use of the suspending 
agent, polyethylene glycol, which has since been eliminated from the 
Depo-Medrol preparation. For epidural injections, betamethasone 
provides immediate and long term duration of action. It  is highly soluble, 
and contains no harmful preservatives. other commonly used preparations 
for spinal injections include methylprednisolone (Depo-Medrol) and 
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triamcinolone . Isotonic saline is the only other injectable medium used 
frequently around the spine with no reported adverse reactions. 
 
EPIDURAL CORTISONE INJECTIONS 
 Epidural injections in the cervical, thoracic, and lumbosacral spine 
were developed to diagnose and treat spinal pain.  
 
 Information   obtained from epidural injections (ESI) can be 
helpful in confirming pain generators that are responsible for a patient’s 
discomfort. Structural abnormalities do not always cause pain, and 
diagnostic injections can help to correlate abnormalities seen on imaging 
studies with associated pain complaints.  
 
 In addition, epidural injections can provide pain relief during the 
recovery phase of disc or nerve root injuries and allow patients to 
increase their level of physical activity. Because severe pain from an 
acute disc injury with or without radiculopathy often is time limited, 
therapeutic injections help to manage pain and may alleviate or decrease 
the need for oral analgesics 
 
LUMBAR EPIDURAL INJECTION 
 Certain clinical trends are apparent with lumbar epidural steroid 
injections.    When nerve root injury is associated with a disc herniation 
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or lateral bony stenosis, most patients who received substantial relief of 
leg pain from a well-placed transforaminal injection, even if temporary, 
benefit from surgery for the radicular pain.  
 
Table 3   Common Corticosteroids Used in Spinal Interventions 
Compared   with Hydrocortisone 
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Relative 
Anti-
inflammatory 
potency 
1 5 5 25 
pH 5.0-7.0 7-8 4.5-6.5 6.8-7.2 
Onset Fast Slow Moderate Fast 
Duration of 
action Short Intermediate Intermediate Long 
Concentration 
(mg/mL) 50 40-80 20 6 
Relative 
mineralocorticoid 
activity 
2+ 0 0 0 
 
 Patients who do not respond and who have had radicular pain for at 
least 12 months are unlikely to benefit from surgery. Patients with back 
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and leg pain of an acute nature (<3 months) respond better to epidural 
corticosteroids.  
 
 Unless a significant re-injury results in an acute disc or nerve root 
injury, postsurgical patients tend to respond poorly to epidural 
corticosteroids. 
  
  
 
  
 
Figure 15A : Transforaminal Approach  
 
 
 
 
 
 
Figure 15B : Transforaminal & Interlaminar Approach 
 
Materials & Methods 
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MATERIALS AND METHODS 
 This study was conducted at Rajiv Gandhi Government General 
Hospital Chennai from March 2014 to Sep 2015.  
 
 One hundred patients with back pain documented with lumbar disc 
disease treated initially with rest, analgesics and physiotherapy for at least 
six weeks were included in the study and were treated with epidural 
steroid injection. The protocol was approved by ethical committee.  
 
 Patients to participate in this study were documented. Patients with 
lumbar disc disease were given transforaminal epidural or intralaminar 
epidural steroid injection since 1/3/2014 in Ortho OT of our institute & 
Pain clinic OT.  
 
INCLUSION CRITERIA 
1. Patients with duration of back pain and radiculopathy for more than 
6 months with radiological evidence (MRI & X- RAY) of lumbar 
disc disease. 
2. MRI scan showing an herniated nucleosus pulposus (HNP) of 
intervertebral disc with less than 50% intervertebral canal 
narrowing with manifestations of backache and radiculopathy.   
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HNPs at various interspaces (L3–L4, L4–L5, L5–S1) and with 
differing axial presentations (e.g., far lateral, paracentral, and 
central protrusion) were examined. 
3. Age group between 18 to 65 years. 
.          
  EXCLUSION CRITERIA 
1) Patients with more than 2 level lumbar disc disease. 
2) Patients with progressive neurological deficits. 
3) Patients who underwent prior lumbar surgery. 
4) Patients with a large herniation with severe central or foraminal 
stenosis on MRI, 
5) Coagulation disorder. 
6) Patients with a history of anaphylaxis to local anesthetics or 
corticosteroid. 
 
 Patients who met inclusion criteria were obtained informed consent 
after explaining all risks, benefits, objectives and outcomes of the study.  
They were all explained about nature of study.  
 
Two groups were assigned 
GROUP 1- TRANSFORAMINAL EPIDURAL STEROID   (TFESI) 
GROUP 2- INTERLAMINAR EPIDURAL STEROID   (ILESI) 
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 Each group con tains 50 patients. Pt having predominant unilateral 
symptoms were given transforaminal steroids. Other patients on random 
basis were equally divided.  These patients were followed for one year.  
No patients were missed. 
 
The following methods were used to apply the epidural steroid.   
 
Figure 16A : Tuohy epidural needle 
 
 
 
Figure 16B : Tuohy epidural needle    
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TRANSFORAMINAL   LUMBAR   EPIDURAL   INJECTION 
• Place the patient prone on a fluoroscopy compatible surgical table. 
Under sterile aseptic precautions, the parts (fig 17) above and below 
the interspace to be injected were prepared and draped.  
• A 22-gauge, 4 ¾ inch spinal needle is then inserted and advanced 
within the anesthetized soft tissue track under fluoroscopy guidance 
until contact is made near the junction of the superior articular process 
and lower edge of the superior transverse process. 
• The spinal needle is retracted 2 to 3 mm, redirected towards the base 
of the appropriate pedicle and advanced it slowly to the 6-o’clock 
position of the pedicle under fluoroscopy. Adjusted the C-arm to a 
lateral projection to confirm the position, and then returned the C-arm 
to the anteroposterior view.  
• Confirmed placement in safe triangle. Safe triangle roof is formed by 
pedicle, exiting nerve root forms tangential base and vertebral body 
forms lateral border.   
• S1 was accessed with 22 gauge 3.5-inch spinal needle. Needle placed 
under fluoroscopic guidance in upper outer quadrant of ipsilateral S1 
foramen. 
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• The stylet was removed and 1 mL of iohexol nonionic contrast agent 
was injected slowly to produce a perineurosheathogram observed 
adequate dye pattern. 
 
 At each level of nerve root, one ml of iohexol nonionic contrast 
agent was injected after positioning under C-ARM guidance. Needle 
position re-adjusted if fluoroscopy didn’t reveal flow to ipsilateral nerve 
root.  
 
 After documenting adequate flow of contrast to target site and no 
blood or cerebrospinal fluid was aspirated, 2ml of triamicinolone (each 
ml containing 40 mg) with 1ml of preservative free lignocaine were 
given. Injection were never given more than 2 levels to avoid systemic 
side effects of steroid.  
 
         The patients in Group I with the total of 50 patients (with average 
age of 47.1, with second dose of steroid in 21 poor responders after 4 
weeks apart, total 72 injections of TFESI) received an average of 1.42  
TFESI  were followed for 12 months. 
 
 
     
  
  
Figure 17A : Aseptic Prepartion 
 
 
Figure 17B : Safe Triangle 
 
 
 
Figure 18 : Injecting Contrast 
 
 
Figure 19 : Establishing Contrast Pattern 
 
 
 Figure 20  : Lateral view of LS spine showing needle in position 
 
 
Figure 21: AP view of LS spine showing needle in position 
 
 
 
  
 
 
 
Figure 22 : Injecting Transforaminal Epidural Steroid 
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INTERLAMINAR LUMBAR EPIDURAL INJECTION 
  Patient prone position on a fluoroscopy compatible surgical table. 
Aseptically prepared the part with isopropyl alcohol and povidone-iodine 
several segments above and below the laminar interspace to be injected. 
Draped the part in a sterile fashion.  
 
 Under anteroposterior fluoroscopy view, identified the target 
interlaminar space. Using a 27-gauge, ¼ -inch needle, anesthetized the 
part over the target interspace on the side of the patient’s symptom with  
1  mL of 1% preservative-free lignocaine without epinephrine. 
 
  22-gauge, 31/2 -inch spinal needle inserted vertically until contact is 
made with the upper edge of the inferior lamina at the target interspace, 1 
to 2 cm lateral to the caudal tip of the inferior spinous process under 
fluoroscopy. Anesthetized the lamina with 1-2 mL of 1% preservative-
free lidocaine without epinephrine. Anesthetized the soft tissue with 2 mL 
of 1% lidocaine as the spinal needle is withdrawn.  
 
 Nicked the skin with an 18-gauge hypodermic needle, and inserted 
a 17-gauge, 31/2 -inch Tuohy epidural needle. Advanced it within the soft 
tissue track vertically until contact made with the lamina under 
fluoroscopic image guidance.  
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  “Walk off” the lamina with the Tuohy needle onto the ligamentum 
flavum. Removed the stylet from the Tuohy needle, and attached a 10-mL 
syringe filled halfway with air and sterile saline to the Tuohy needle. 
Advanced the Tuohy needle into the epidural space using the loss-of-
resistance technique. Avoided lateral needle placement to decrease the 
likelihood of encountering an epidural vein or adjacent nerve root. 
Removed the stylet when loss of resistance has been achieved. Aspirated 
to check for blood or CSF. If neither blood nor CSF is present, removed 
the syringe from the Tuohy needle and attached a 5-mL syringe 
containing 2 mL of nonionic contrast dye.   
 
 Epidural placement confirmed by an epidurogram with the iohexol.  
Placement documented with flouroscopy.            
 
 Removed the 5-mL syringe, and placed on the Tuohy needle. 10-
mL syringe containing 1 mL of 1% preservative-free lidocaine and 2 mL 
of 40 mg/mL triamicinolone. 
 
 Inject the corticosteroid preparation slowly into the epidural space.  
Group II total 50 patients with an average age 45.2 had 30 poor 
responders. They were given second dose 4 weeks later. ILESI Group  
received an average of 1.6 ESIs ( total of 80)  and were followed for  12 
months.  
 
Figure 23A : Posteroanterior view of lumbar interlaminar 
epidurogram showing characteristic contrast flow pattern 
 
 
 
Figure 23 B : Lateral   radiograph of lumbar epidurogram. 
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Self-directed lumbar stabilization programme were given for both groups. 
It consisted of  
1) Abdominal strengthening exercises 
2) Lumbar paraspinal strengthening 
3) Hip flexibility 
4) Hamstring flexibility 
Started immediately after injection in both study groups. 
 
Assessment and Follow-up 
 Compliance was ensured by therapeutic exercises reinforcement 
during follow-up visits.  
 
Outcome of treatment was   measured by   
1) PATIENT SATISFACTION SCALE.  
It had choice options as 
                 0 (poor)  
                 1 (fair) 
                 2 (good)  
                 3 (very good)  
                 and 4 (excellent).  
2)  ROLAND MORRIS LOW BACK PAIN DISABILITY 
QUESTIONNAIRE (RMDQ) showing improvement by an increase in 
score; 
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3)  Measurement of FINGER-TO FLOOR DISTANCE. It is done with 
the patient in fully tolerated hip flexion; 
4) VISUAL NUMERIC PAIN SCALE similar to the visual analog scale 
with a range of options from 0 (no pain) to 10 (worst pain).     
Outcome measures were assessed as follows:  
1) Before and after treatment, then at 2 weeks, 1month, 3 month, 6 
months and 12 months by a staff nurse blinded to programme. 
2) Pt advised not to use Narcotics or NSAID medication during 
study period. During follow up,  patients were assessed for 
neurologic detoriation, worsening of pain, also new development 
of pain. Patients who failed to respond were given additional one 
dose of injection through same approach. Time interval between 2 
doses were minimum of one month.   
 
A successful outcome defined as  
- improvement of a patient satisfaction score of 2  (good) or 3 
(very good),  4 (excellent). (Improvement of at least 2 scores) 
 
- improvement on the Roland-Morris Disability score of 5 or 
more,  
- and pain reduction greater than 50% (with visual numeric scale 
of 1,2,3)  at least 3 months after treatment.  
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The Roland-Morris Low Back Pain and Disability Questionnaire 
I stay at home most of the time because of my back. 
I change position frequently to try to get my back comfortable. 
I walk more slowly than usual because of my back. 
Because of my back, I am not doing any jobs that I usually do around the 
house. 
Because of my back, I use a handrail to get upstairs. 
Because of my back, I lie down to rest more often. 
Because of my back, I have to hold on to something to get out of an easy chair. 
Because of my back, I try to get other people to do things for me. 
I get dressed more slowly than usual because of my back. 
I only stand up for short periods of time because of my back. 
Because of my back, I try not to bend or kneel down. 
I find it difficult to get out of a chair because of my back. 
My back is painful almost all of the time. 
I find it difficult to turn over in bed because of my back. 
My appetite is not very good because of my back. 
I have trouble putting on my sock because of the pain in my back. 
I can only walk short distances because of my back pain. 
I sleep less well because of my back. 
Because of my back pain, I get dressed with the help of someone else. 
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I sit down for most of the day because of my back. 
I avoid heavy jobs around the house because of my back. 
Because of back pain, I am more irritable and bad tempered with people than 
usual. 
Because of my back, I go upstairs more slowly than usual. 
I stay in bed most of the time because of my back. 
 
VISUAL NUMERIC RATING SCALE   
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RESULTS 
 
 In TFESI group, 36 patients out of 50   showed improvements at 
the end of one year where as in ILESI group, only 28  showed significant 
improvements at the end of  year as per Patient Satisfaction Score study.  
 
 In TFESI Group, 8 patients didn’t show any improvement (6 
patients absent response, 2 patients negligible improvement, among them 
2 were females) 
 
 In ILESI Group, 20 patients didn’t show any improvement (13 
patients absent response, 7 patients negligible improvement, among them 
11 were females).  
 
 Complications, such as dural puncture, excessive bleeding or 
infection were   not reported in both groups. But headache was reported 
in 2 patients in ILESI. 
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Table 4-  Frequency table for sex in each sub cohort 
 
TREATMENT TYPE Frequency Percent Valid Percent Cumulative Percent 
TFESI 
Female 16 32.0 32.0 32.0 
Male 34 68.0 68.0 100.0 
Total 50 100.0 100.0  
ILESI 
Female 19 38.0 38.0 38.0 
Male 31 62.0 62.0 100.0 
Total 50 100.0 100.0  
 
 
 
 
 
Chart Showing Sex Distribution.  
Female (Blue Colour) And Male (Orange Colour) 
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Table 5A. Descriptives- Mean and Standard deviation in TFESI group. 
Descriptive Statistics 
TREATMENT TYPE N Minimum Maximum Mean Std. Deviation 
TR
A
N
SF
O
R
A
M
IN
A
L 
EP
ID
U
R
A
L 
G
R
O
U
P 
Roland@pre treatment 50 12 20 16.52 2.002 
Roland@1month 50 6 17 11.04* 2.579 
Roland@3month 50 6 17 11.70 2.558 
Roland@6month 50 7 18 12.30 2.636 
Roland@12month 50 7 19 13.14 2.828 
Finger@Pre treatment 50 40 80 63.16 8.505 
Finger@1month 50 15 69 32.52* 14.336 
Finger@3month 50 16 69 34.94* 14.596 
Finger@6month 50 18 75 37.14* 15.931 
Finger@12month 50 19 75 40.18 16.768 
Satisfication@Pre 
treatment 50 0 1 .26 .443 
Satisfication@1month 50 0 4 2.96* 1.195 
Satisfication@3month 50 1 4 2.70* 1.147 
Satisfication@6month 50 0 4 2.54* 1.199 
Satisfication@12month 50 0 4 2.26* 1.175 
Visual@Pre treatment 50 7 9 8.58 .538 
Visual@0 50 1 8 3.30* 2.197 
Visual@15th day 50 1 8 3.74* 2.284 
Visual@1month 50 1 9 4.02* 2.369 
Visual@3month 50 1 9 4.06* 2.469 
Visual@6month 50 1 9 4.32* 2.543 
Visual@1y 50 2 9 4.58 2.635 
 
*means study showing successful results. *In RMDQ mean reduction of disability by 5 
scores. *In finger floor distance analysis 25 cm increase in finger floor distance analysis.  
In patient satisfaction score by mean improvement of 2 scores. *In visual numeric scale by 
mean reduction of 50 percent of pain scores. Visual 0 - means on day of treatment. 
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* Table 5B. Descriptives Mean and Standard deviation in ILESI group. 
TREATMENT TYPE N Minimum Maximum Mean Std. Deviation 
IN
TE
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M
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R
O
U
P 
Roland@Pre treatment 50 13 19 16.38 1.413 
Roland@1month 50 10 16 13.38 1.817 
Roland@3month 50 10 17 13.50 1.876 
Roland@6month 50 10 17 13.58 1.939 
Roland@12month 50 10 19 13.84 2.064 
Finger@Pre treatment 50 50 70 63.84 5.250 
Finger@1month 50 23 69 44.62 14.168 
Finger@3month 50 23 69 45.18 14.512 
Finger@6month 50 23 69 45.64 14.602 
Finger@12month 50 23 69 46.16 14.829 
Satisfication@Pretreatment 50 0 1 .02 .141 
Satisfication@1month 50 0 4 1.94 1.316 
Satisfication@3month 50 0 4 1.78 1.282 
Satisfication@6month 50 0 4 1.76 1.287 
Satisfication@12month 50 0 4 1.70 1.282 
Visual@Pre treatment 50 8 9 8.84 .370 
Visual@0 50 2 9 4.70 2.605 
Visual@15th day 50 2 9 4.92 2.747 
Visual@1month 50 2 9 5.06 2.810 
Visual@3month 50 2 9 5.10 2.852 
Visual@6month 50 2 9 5.20 2.814 
Visual@1year 50 2 9 5.30 2.757 
Visual 0 - means on day of treatment 
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Table 6. Descriptives   p value study 
 
 Treatment N Mean SD P value 
Roland@Pre treatment 
TFESI 50 16.52 2.002 
0.687 
ILESI 50 16.38 1.413 
Roland@1month 
TFESI 50 11.04 2.579 
*<0.001** 
ILESI 50 13.38 1.817 
Roland@3month 
TFESI 50 11.70 2.558 
*<0.001** 
ILESI 50 13.50 1.876 
Roland@6month 
TFESI 50 12.30 2.636 
*0.007** 
ILESI 50 13.58 1.939 
Roland@12month 
TFESI 50 13.14 2.828 
0.161 
ILESI 50 13.84 2.064 
Finger@Pre treatment 
TFESI 50 63.16 8.505 
0.632 
ILESI 50 63.84 5.250 
Finger@1month 
TFESI 50 32.52 14.336 
*<0.001 
ILESI 50 44.62 14.168 
Finger@3month 
TFESI 50 34.94 14.596 
*<0.001 
ILESI 50 45.18 14.512 
Finger@6month 
TFESI 50 37.14 15.931 
*0.006 
ILESI 50 45.64 14.602 
Finger@12month 
TFESI 50 40.18 16.768 
.062 
ILESI 50 46.16 14.829 
Satisfication@Pre 
treatment 
TFESI 50 .26 .443 
<0.001 
ILESI 50 .02 .141 
Satisfication@1month 
TFESI 50 2.96 1.195 
*<0.001 
ILESI 50 1.94 1.316 
Satisfication@3month 
TFESI 50 2.70 1.147 
*<0.001 
ILESI 50 1.78 1.282 
Satisfication@6month 
TFESI 50 2.54 1.199 
*0.002 
ILESI 50 1.76 1.287 
Satisfication@12month 
TFESI 50 2.26 1.175 
*0.025 
ILESI 50 1.70 1.282 
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Visual@Pre treatment 
TFESI 50 8.58 .538 
*0.006 
ILESI 50 8.84 .370 
Visual@0 
TFESI 50 3.30 2.197 
*0.005 
ILESI 50 4.70 2.605 
Visual@15days 
TFESI 50 3.74 2.284 
*0.022 
ILESI 50 4.92 2.747 
Visual@1month 
TFESI 50 4.02 2.369 
*0.048 
ILESI 50 5.06 2.810 
Visual@3month 
TFESI 50 4.06 2.469 
0.054 
ILESI 50 5.10 2.852 
Visual@6month 
TFESI 50 4.32 2.543 
0.104 
ILESI 50 5.20 2.814 
Visual@1year 
TFESI 50 4.58 2.635 
0.185 
ILESI 50 5.30 2.757 
*means study significant with p value of <0.05 
 
 
Table 7-  T-Test  study of standard error of mean. 
 
Group Statistics 
 Treatment type N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Roland @Pre treatment 
TFESI 50 16.52 2.002 .283 
ILESI 50 16.38 1.413 .200 
Roland@1month 
TFESI 50 11.04 2.579 .365 
ILESI 50 13.38 1.817 .257 
Roland@3month 
TFESI 50 11.70 2.558 .362 
ILESI 50 13.50 1.876 .265 
Roland@6month 
TFESI 50 12.30 2.636 .373 
ILESI 50 13.58 1.939 .274 
Roland@12month 
TFESI 50 13.14 2.828 .400 
ILESI 50 13.84 2.064 .292 
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Finger @Pre treatment 
TFESI 50 63.16 8.505 1.203 
ILESI 50 63.84 5.250 .743 
Finger@1month 
TFESI 50 32.52 14.336 2.027 
ILESI 50 44.62 14.168 2.004 
Finger@3month 
TFESI 50 34.94 14.596 2.064 
ILESI 50 45.18 14.512 2.052 
Finger@6month 
TFESI 50 37.14 15.931 2.253 
ILESI 50 45.64 14.602 2.065 
Finger@12month 
TFESI 50 40.18 16.768 2.371 
ILESI 50 46.16 14.829 2.097 
Satisfication@Pretreatment 
TFESI 50 .26 .443 .063 
ILESI 50 .02 .141 .020 
Satisfication@1month 
TFESI 50 2.96 1.195 .169 
ILESI 50 1.94 1.316 .186 
Satisfication@3month 
TFESI 50 2.70 1.147 .162 
ILESI 50 1.78 1.282 .181 
Satisfication@6month 
TFESI 50 2.54 1.199 .170 
ILESI 50 1.76 1.287 .182 
Satisfication@12month 
TFESI 50 2.26 1.175 .166 
ILESI 50 1.70 1.282 .181 
Visual @Pre treatment 
TFESI 50 8.58 .538 .076 
ILESI 50 8.84 .370 .052 
Visual@0 
TFESI 50 3.30 2.197 .311 
ILESI 50 4.70 2.605 .368 
Visual@15days 
TFESI 50 3.74 2.284 .323 
ILESI 50 4.92 2.747 .388 
Visual@1month 
TFESI 50 4.02 2.369 .335 
ILESI 50 5.06 2.810 .397 
Visual@3month 
TFESI 50 4.06 2.469 .349 
ILESI 50 5.10 2.852 .403 
Visual@6month 
TFESI 50 4.32 2.543 .360 
ILESI 50 5.20 2.814 .398 
Visual@1year 
TFESI 50 4.58 2.635 .373 
ILESI 50 5.30 2.757 .390 
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Table 8- ROLAND MORRIS DISABILITY - MEAN SCORE  
ANALYSIS 
 
Table 8A- ROLAND MORRIS DISABILITY MEAN SCORE  ANALYSIS in TFESI  
  Mean SD 
Roland-Pre treatment 16.52 2.00 
Roland-1month  11.04* 2.58 
Roland-3month     11.70** 2.56 
Roland-6month                12.30 2.64 
Roland-12month 13.14 2.83 
*mean reduction of 5 scores of RMDQ significant at 1st month.  
** mean reduction of almost 5 (4.82) by 3rd month 
 
 
Table 8B- ROLAND MORRIS DISABILITY MEAN SCORE  ANALYSIS in  ILESI  
  Mean SD 
Roland-Pre treatment 16.38 1.41 
Roland-1month 13.38 1.82 
Roland-3month 13.50 1.88 
Roland-6month 13.58 1.94 
Roland-12month 13.84 2.06 
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 Pre procedure Roland Morris Disability mean score was 16.52 and 
it got reduced to 11.04 by end of one month, was 11.70 by 3rd month, by 
6th month 12.30 and by the end of the study period, the mean Roland-
Morris score in TFESI was 13.14  
 
        In ILESI group, pre procedure Roland –Morris Disability mean was 
16.38 and it got reduced to 13.38 by end of one month, was 13.50 by 3rd 
month, by 6th month 13.580and by the end of the study period , the mean 
Roland-Morris score was 13.84   
 
ROLAND MORRIS DISABILTY MEAN SCORE 
 
 
 
       Reduction of 5 score or more after procedure considered significant. 
Only TFESI group achieved significant reduction in disability by mean 
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score of 5.48 by 1st  month. Mean reduction was 4.82 for 3rd  month, the 
mean reduction was 4.22 by 6 months.  By 12 months mean reduction of 
disability was 3.38. 
 
 ILESI group reduction in disability mean score was  3.00 by 1 
month. Mean reduction was 2.88 for 3rd  month . The mean reduction was 
2.80 by 6 months.   By 12 months mean reduction of disability was 2.54. 
 
 
 
No of patients showing good response by Roland 
Morris Disability Improvement 
 
 
 
 
 
37
16
28
14
24
13
20
9
0
5
10
15
20
25
30
35
40
TFESI
1M
ILESI IM TFESI
3M
ILESI 3M TFESI
6M
ILESI 6M TFESI
12M
ILESI
12M
N
o 
of
 P
at
ie
nt
s
Observation During Study Period
NO OF PATIENTS SHOWING GOOD RESPONSE
60 
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VISUAL NUMERIC SCALE ASSESSMENT 
 
Visual numeric scale 9,10- worst pain. 1,2 – mild pain 
 
 
 In TFESI,  the Visual Numeric Pain pre procedure  mean was 8.58 
and after procedure it got reduced to 3.3 immediately,  4.02 by end of one 
month, was 4.06  by 3rd month, by 6th month 4.32 and by end of the year 
was 4.58 
 
 In ILESI, the Visual Numeric Pain pre procedure  mean was 8.84 
and after procedure it got reduced to 4.7 immediately, to 5.06 by end of  
one month, was 5.1 by  3rd month. By 6th month 5.2 and by end of the 
year was 5.3. 
 
 Fifty percent mean reduction was noticed only in transforaminal  
group till end of six months. Results were significant only in 
transforaminal  group alone. 
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VISUAL NUMERIC SCALE -RESPONDERS OVER TIME       
PERIOD 
 
 
 
Excellent response       - Visual Numeric Scale of 1 
Very Good response      - Visual Numeric Scale of 2 
Good response          - Visual Numeric Scale of 3. 
 
10
15
14
8 6
9
9 19
11
TFESI O ILESI 0 TFESI 12M ILESI 12M
N
o 
of
 P
at
ie
nt
s
EXCELLENT VERY GOOD GOOD
63 
 
 
 In transforaminal group, 34 patients showed significant reduction 
in pain    immediately, whereas in in ILESI group 27 patients showed 
significant reduction of pain immediately. But at the year end, 23 patients 
in TFESI and 17 patients in ILESI had a good  pain relief. But excellent 
response of more than 80 percent reduction of pain noticed immediately 
in  TFESI group  vanished over the time period.  
 
 Ten patients in TFESI had excellent response of pain reduction by 
more than eighty percent ( visual numeric scale of one ). But by the end 
of six months only one patient was in visual numeric scale of one. But 27 
patients in TFESI group had more than sixty percent reduction in pain by 
end of study period.  
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VISUAL NUMERIC SCALE - MEAN RESPONSE OVER TIME 
PERIOD 
 
 
 
 Diagram showing comparision of efficacy of TFESI & ILESI over 
a study period in pain relief. Chart showing immediate relief in pain and 
efficacy more in TFESI.  
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FINGER FLOOR DISTANCE ANALYSIS  
                      
            
            Pre procedure Finger to floor distance mean was 63.36 cm and it 
got reduced to 32.52 cm by end of one month, was 34.94 cm by 3rd 
month, by 6th month 37.14 and by the end of the study period, the mean  
in TFESI was 40.18 cm.  
 
           Pre procedure Finger to floor distance mean was 63.84 cm and it 
got reduced to 44.62 cm by end of one month, was 45.18 cm by 3rd 
month, by 6th month 45.68 and by the end of the study period, the mean  
in ILESI was 46.16 cm.   
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 Mean improvent of 25 cm to floor distance noticed only in TFESI 
group. And improvement was seen up to six months. But by the end of 
study  period it was 23 cm in TFESI which is also good improvement. 
  
FINGER @PRE FINGER @1M FINGER @M FINGER @6M
FINGER
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PATIENT SATISFACTION SCORE ANALYSIS 
 
 
 Patient satisfaction score - 0 (poor), 1 (fair), 2 (good), 3 (very 
good), and 4 (excellent) 
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PATIENT SATISFACTION SCORE PRIOR TO TREATMENT  
 
 
 In TFESI group 37 and in ILESI group 49 patients were in poor response 
category prior to treatment. 
 
PATIENT SATISFACTION SCORE RESPONSE I MONTH AFTER TREATMENT  
 
 
 
 At 1 month after treatment 24 patients in TFESI group and 6 patients in ILESI 
group showed excellent satisfaction (score 4).  
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PATIENT SATISFACTION SCORE RESPONSE 3 MONTHS AFTER TREATMENT  
 
 
 At 3 month after treatment 15 patients in TFESI group and 2 patients in  ILESI 
group showed excellent satisfaction (score 4). 17 patients in TFESI group and 17 
patients in ILESI group showed very good satisfaction (score 3).  
 
PATIENT SATISFACTION SCORE RESPONSE 6 MONTHS AFTER TREATMENT  
 
 
 At 6 months after treatment 13 patients in TFESI group and 2 patients in 
ILESI group showed excellent satisfaction. 15 patients in TFESI group and 17 
patients in ILESI group showed very good satisfaction.  
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PATIENT SATISFACTION SCORE RESPONSE I2 MONTHS AFTER TREATMENT  
 
 
          At 12 months after treatment 7 patients in TFESI group and 2 patients in ILESI 
group showed excellent satisfaction. 17 patients in TFESI group and 15 patients in 
ILESI group showed very good satisfaction.  
   
 The Patient Satisfaction mean pre procedure in TFESI   was 0.26 and after 
procedure it got improved   to 2.96 by end of one month, slightly decreased to 2.70 by 
3rd month with further declinement to 2.54 by 6th month and bye end of the year it was 
2.26 
 
 The Patient Satisfaction mean pre procedure in ILESI was 0.02 and after 
procedure it got improved   to   1.94 by end of one month, slightly decreased to 1.78 
by 3rd month with further  declinement  to 1.76 by 6th month  and by end of the year it 
was 1.70 
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 Overall, 72% of the patients in Group 1 had a successful outcome, attaining 
maximal improvement within 4 weeks of treatment, overall improvement was 56% in 
ILESI group. Documented period of delay between final TFESI and improvement was 
4 weeks.     
 
         The difference in outcomes between Groups 1 and 2 was statistically significant 
(P @ <0.001**). This difference was maintained throughout the duration of the study. 
 
            Factors associated with the unsuccessful outcome in Group 1 were presence of 
development of new degenerative   spondylolisthesis in three patients   and symptom 
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duration exceeding 1 year in 6 patients. However, statistical significance cannot be 
determined because of the small sample for each subgroup of patients. 
 
  Factors associated with the unsuccessful outcome in   ILESI Group  were 
presence of development of degenerative  spondylolisthesis  in five patients   and 
symptom duration exceeding 1 year in 13patients. However,  statistical significance 
cannot be determined because of  the small  sample for each subgroup of patients. 
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Table 9-     Independent Samples Test for descriptives 
  Levene's Test for Equality of Variances t-test for Equality of Means 
  
F Sig. t df Sig. (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
  Lower Upper 
Roland@pre 
Equal variances 
assumed 5.730 .019 .404 98 .687 .140 .347 -.548 .828 
Equal variances not 
assumed   .404 88.089 .687 .140 .347 -.549 .829 
Roland@1month 
Equal variances 
assumed 4.707 .032 -5.245 98 .000* -2.340 .446 -3.225 -1.455 
Equal variances not 
assumed   -5.245 88.029 .000* -2.340 .446 -3.227 -1.453 
Roland@3month 
Equal variances 
assumed 5.084 .026 -4.013 98 .000* -1.800 .449 -2.690 -.910 
Equal variances not 
assumed   -4.013 89.898 .000* -1.800 .449 -2.691 -.909 
Roland@6month 
Equal variances 
assumed 4.998 .028 -2.766 98 .007* -1.280 .463 -2.198 -.362 
Equal variances not 
assumed   -2.766 90.010 .007* -1.280 .463 -2.199 -.361 
Roland@12month 
Equal variances 
assumed 6.060 .016 -1.414 98 .161 -.700 .495 -1.683 .283 
Equal variances not 
assumed   -1.414 89.653 .161 -.700 .495 -1.684 .284 
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Finger@Pre 
Equal variances 
assumed 8.095 .005 -.481 98 .632 -.680 1.414 -3.485 2.125 
Equal variances not 
assumed   -.481 81.608 .632 -.680 1.414 -3.492 2.132 
Finger@1month 
Equal variances 
assumed .437 .510 -4.245 98 .000* -12.100 2.850 -17.757 -6.443 
Equal variances not 
assumed   -4.245 97.986 .000* -12.100 2.850 -17.757 -6.443 
Finger@3month 
Equal variances 
assumed .282 .596 -3.518 98 .001* -10.240 2.911 -16.016 -4.464 
Equal variances not 
assumed   -3.518 97.997 .001* -10.240 2.911 -16.016 -4.464 
Finger@6month 
Equal variances 
assumed .110 .741 -2.781 98 .006* -8.500 3.056 -14.565 -2.435 
Equal variances not 
assumed   -2.781 97.266 .007* -8.500 3.056 -14.565 -2.435 
Finger@12month 
Equal variances 
assumed .634 .428 -1.889 98 .062 -5.980 3.166 -12.262 .302 
Equal variances not 
assumed   -1.889 96.556 .062 -5.980 3.166 -12.263 .303 
Satisfication@Pre 
Equal variances 
assumed 93.802 .000 3.649 98 .000 .240 .066 .109 .371 
Equal variances not 
assumed   3.649 58.881 .001 .240 .066 .108 .372 
Satisfication@1month Equal variances assumed .221 .640 4.059 98 .000* 1.020 .251 .521 1.519 
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Equal variances not 
assumed   4.059 97.100 .000* 1.020 .251 .521 1.519 
Satisfication@3month 
Equal variances 
assumed 1.170 .282 3.781 98 .000* .920 .243 .437 1.403 
Equal variances not 
assumed   3.781 96.811 .000* .920 .243 .437 1.403 
Satisfication@6month 
Equal variances 
assumed .614 .435 3.136 98 .002* .780 .249 .286 1.274 
Equal variances not 
assumed   3.136 97.514 .002* .780 .249 .286 1.274 
Satisfication@12month 
Equal variances 
assumed 1.132 .290 2.278 98 .025* .560 .246 .072 1.048 
Equal variances not 
assumed   2.278 97.265 .025* .560 .246 .072 1.048 
Visual@Pre 
Equal variances 
assumed 29.550 .000 -2.815 98 .006 -.260 .092 -.443 -.077 
Equal variances not 
assumed   -2.815 86.925 .006 -.260 .092 -.444 -.076 
Visual@0 
Equal variances 
assumed 4.707 .032 -2.905 98 .005* -1.400 .482 -2.356 -.444 
Equal variances not 
assumed   -2.905 95.288 .005* -1.400 .482 -2.357 -.443 
Visual@15 
Equal variances 
assumed 6.585 .012 -2.336 98 .022* -1.180 .505 -2.183 -.177 
Equal variances not 
assumed   -2.336 94.844 .022* -1.180 .505 -2.183 -.177 
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Visual@1month 
Equal variances 
assumed 7.454 .008 -2.001 98 .048* -1.040 .520 -2.071 -.009 
Equal variances not 
assumed   -2.001 95.279 .048* -1.040 .520 -2.072 -.008 
Visual@3month 
Equal variances 
assumed 6.637 .011 -1.949 98 .054 -1.040 .533 -2.099 .019 
Equal variances not 
assumed   -1.949 96.038 .054 -1.040 .533 -2.099 .019 
Visual@6month 
Equal variances 
assumed 3.886 .052 -1.641 98 .104 -.880 .536 -1.944 .184 
Equal variances not 
assumed   -1.641 97.012 .104 -.880 .536 -1.945 .185 
Visual@1y 
Equal variances 
assumed 1.438 .233 -1.335 98 .185 -.720 .539 -1.790 .350 
Equal variances not 
assumed   -1.335 97.799 .185 -.720 .539 -1.790 .350 
 
Independent T test was performed to find the mean difference between two groups. (* means significant results).  It is found that results are 
significant in   RMDQ at 1month, 3rd  month, 6th month and in Finger Floor Distance analysis at 1st month, 3rd  month, 6th month and in Patient 
Satisfaction Score  analysis  at  1st month, 3rd  month, 6th month, also in12th month and in Visual Numeric Scale Assessment in 1st month. 
 
  
  
77 
 
 
Table 10   Case Processing Summary 
Valid Missing Total 
N Percent N Percent N Percent 
100 100.0% 0 .0% 100 100.0% 
 
Table 11   Chi Square Tests 
 Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) 
Pearson Chi-Square .396a 1 .529  
Continuity Correctionb .176 1 .675  
Likelihood Ratio .396 1 .529  
Fisher's Exact Test    .675 
N of Valid Casesb 100    
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 17.50. 
b. Computed only for a 2x2 table 
 
Table  12 Group Statistics 
 type@tr N Mean Std. Deviation Std. Error Mean 
RMDQ IMPROVEMENT 
@1month   
TF 50 33.5809 11.27160 1.59404 
IL 50 17.9725 11.72675 1.65841 
       RMDQ IMPROVEMENT 
@3month   
TF 50 29.4822 11.43955 1.61780 
IL 50 17.2642 11.82078 1.67171 
RMDQ IMPROVEMENT @ 
6month   
TF 50 25.7802 11.99328 1.69611 
IL 50 16.8184 11.84312 1.67487 
RMDQ IMPROVEMENT @12 
month   
TF 50 20.6310 13.44427 1.90131 
IL 50 15.2404 12.30675 1.74044 
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RMDQ-  ROLAND-MORRIS  LOW BACK PAIN DISABILITY QUESTIONNAIRE  
Table 13 Independent Samples Test Levene's Test for Equality of Variances 
 
Levene's Test for 
Equality of Variances t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
RMDQ 
IMPROVEMENT 
@1month   
Equal variances 
assumed .172 .679 6.785 98 .000* 15.60842 2.30029 11.04358 20.17326 
Equal variances not 
assumed   6.785 97.847 .000* 15.60842 2.30029 11.04349 20.17335 
RMDQ 
IMPROVEMENT 
@3month   
Equal variances 
assumed .132 .717 5.252 98 .000* 12.21794 2.32635 7.60138 16.83450 
Equal variances not 
assumed   5.252 97.895 .000* 12.21794 2.32635 7.60132 16.83456 
RMDQ 
IMPROVEMENT 
@6month   
Equal variances 
assumed .003 .957 3.760 98 .000* 8.96176 2.38369 4.23141 13.69211 
Equal variances not 
assumed   3.760 97.984 .000* 8.96176 2.38369 4.23140 13.69212 
RMDQ 
IMPROVEMENT 
@12month   
Equal variances 
assumed .359 .551 2.091 98 .039 5.39067 2.57761 .27548 10.50585 
Equal variances not 
assumed   2.091 97.244 .039 5.39067 2.57761 .27498 10.50635 
 
RMDQ-  ROLAND-MORRIS  LOW BACK PAIN DISABILITY QUESTIONNAIRE  
*Means significant results. Significant results noted in 1st month, 3rd month, and at 6th month.  
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DISCUSSION 
Epidural steroid injections are given because  
               
Abnormal concentrations of nociceptive 
and inflammatory mediators around damaged nerve 
 
chemical neuroradiculitis. 25,40 
 
 
      Corticosteroids  inhibit prostaglandin synthesis  and block 
nociceptive C-fiber  conduction. SAAL described high levels of  
Phospholipase A2  level in lumbar disc herniation..26 
 
 Steroids classically work by the abolition of the rate-limiting step 
by the enzyme PLA2 to liberate arachidonic acid from cell membranes.  
 
 No difference in outcome between males and females were noted. 
An initial successful outcome in 72% in TFESI group  and 56% in ILESI 
group  of the current patients was observed over an average follow-up 
period of 12 months.   
 
 Also, the results were obtained with an average of 1.42 & 1.6  
steroid injections in group I & II respectively,  which is significantly 
fewer than the traditionally prescribed 3 to 4 injections.  
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      As per Roland Morris Disability improvement asssessment by first 
month 64% patients had significant reduction of disability in TFESI 
group whereas it was 32% for ILESI group. By the end of study period 
significant disability improvement persisted in 40% in TFESI group, it 
was 18% for ILESI group, which shows even though steroid effects 
detoriates over a period of time, percentage of people achieved persistent 
disability improvement for a significant period of 12 months were more 
in TFESI group.  
 
 As per Visual Numeric Scale 68% had very good relief of pain 
(VNS scale 1,2,3) immediately in TFESI group it was 46 percent for 
ILESI group.   At the end of study period significant relief persisted in 
54% in TFESI group and 34% in ILESI group. It shows pain relief of 
steroid starts very early and lasts longer than disability improvement.  
 
 As per Patient Satisfaction Score  in TFESI group 64% had very 
good satisfaction by 1 month  and by the end of study period it was 48% 
had very satisfied feel, whereas it was 38% for ILESI group initially and 
was 34% by end of the study period.  
 
          It shows effect of steroid detoriates over a time period in majority 
of patients due to progression of disease process. But significant number 
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patients have good response which last up to an year. The effect may 
continue for longer period for which further follow up needed. 
 
 More importantly, the patients in Group 1 attained maximal 
improvement in 2 weeks, as compared with 4 weeks in Group 2.  Direct 
delivery of medication to the exact pathological site in the transforaminal 
approach coupled with the additional use of consistent rehabilitation may 
explain the longer duration of effect and the need for fewer injections.  
 
 Furthermore, the efficacy of ESIs may be explained by their 
presumed four   mechanisms of action:  
1. The steroid and anesthetic  solution, both of which have anti 
nociceptive properties 
2.  The “nerve membrane–stabilizing properties of both the steroid 
and xylocaine 
3. “The “washout” effect of the solution, which decreases the regional 
levels of inflammation mediators such as interleukin-1, tumor 
necrosis factor, and phospholipase A2  
4. The potent anti-inflammatory properties of the steroid.,26,28,41 
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As per NORTH AMERICAN SPINE SOCIETY ( NASS) opinion  
1. No more than two injections be used to attempt to achieve a 
beneficial response in the first instance, and  
2. Thereafter, it seems reasonable to use up to three injections in a 
six month period to reinstate and maintain benefit once it has 
been achieved. 
 In our study also we used only two injection but other studies they 
used 3-4 injections.   
 
Pain improvement 
             As per North American Spine Society (NASS) 2013 opinion – 
“TFESI is recommended to provide relief of radicular pain. TFESI has been 
found to be effective in providing pain relief for at least one month in more 
than fifty percent of patients, with half of these patients continuing to benefit 
from treatment for a year or more.” In our study also 34  patients (68 percent) 
had significant immediate relief. This effect persisted in 27 patients till the 
follow up  period of 12 months. 
 
 Gahribo et al 32 study in 2011 showed pain improvement of 73.4% in 
TFESI group and 44.3% in ILESI group. But he  followed patients only for 3 
weeks.  This result similar to our study which had similar results of   significant 
pain relief as 68% and 46% initially (visual numeric scale group 1-3 mild pain) 
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 As per North American Spine Society  - “Karpinnen et al 43   study 
provides  therapeutic evidence that: (1) LTFESI at four weeks after treatment 
achieves significantly greater improvements in pain and disability  in patients 
with contained herniations, but not in patients with extrusions; and (2) for 
providing at least 75% relief of radicular pain.” In our study also patients had 
significant improvement of more than 80 % reduction by one month. 
 
 But Kolsi et al 35 study did not find any difference in pain relief in both 
groups. Both groups had similar pain relief of 62.8% and 63.5%. His duration 
of study also 28 days. His study group had only 17 patients in group I and 13 
patients in group II.  
 
 Ackerman and Ahmad 31  had 72%  pain improvement by the end of 24 
weeks in transforaminal group and 35.2% in interlaminar group. Out of 30 
patients in transforaminal group 9 patients had complete pain relief. In our 
study also we found  by 24 weeks, 15 patients  with Visual Numeric Scale of 
one and two ( Visual Numeric Scale 1-2 mild pain). Ackerman didn’t use any 
numeric scale to assess pain. He divided patients into complete relief, partial 
relief and no relief.  
 
 Lee et al study  pain relief by the end of one month was 78.0% and 
64.5%  in TFESI and ILESI respectively. By the end of 2 month results were 
68.2% and 51.6% for TFESI  and  ILESI respectively. 
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Functional improvement 
            Rado et al study reported functional improvement as 28.3 in TFESI and 
25.0 in ILESI group by the end of 24 weeks. In our study by the end of 6 
months 48% in TFESI and 26% in ILESI group had significant disability 
improvement of  five scales as per  Roland Morris low back pain 
Disability Questionarre. 
 
 Similarly Chang et al in their study of “Transforaminal Versus 
Interlaminar Approaches to Epidural Steroid Injections: A Systematic 
Review of Comparative Studies for Lumbosacral Radicular Pain” found 
these   two groups showed 15 percent difference in functional efficacy in 
TFESI comparing to ILESI for up to one to 6 months. In  his reviewed 
articles  follow up   period was 2 weeks to 24 weeks.  
 
 Cooper et al42 evaluating the effectiveness of LTFESI in 52 
nonconsecutive patients with degenerative lumbar scoliotic stenosis and 
radiculopathy. Patients  received, on average, 1.3 injections of 80 mg 
triamcinolone with 1.5 cc of 2% lidocaine and were followed for 85.5 
weeks. Outcomes were measured by Numeric Rating Scale, NASS 
Patient Satisfaction Index and adapted Stucki Outcome Questionnaire 
pain and function scores. Successful outcome was defined as a patient 
satisfaction index of one or two, greater than two point improvement on 
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the NRS along with the summary pain and function scores.  Success 
noted in 59.6% at one week, 55.8% at one month, 44.2% at three months, 
37.2% at one year and 27.3% at two years. 
 
 Similarly Hospital For Special Surgery - Spine unit study   had 
functional improvement of 14 percent disability improvement in TFESI group. 
In our study we had 20.6 percent mean disability improvement in TFESI group 
and 15.2 percent mean disability improvement in ILESI group by the end of  
study period.38 
 
 Riew et al 44 performed a prospective RCT to determine the 
effectiveness of selective nerve root injections. Of the 55 consecutive patients, 
27 were randomly assigned to receive bupivacaine alone and 28 received   
bupivacaine with betamethasone. At mean follow-up of 23 months (13-28 
months. The difference in operative rates between the two groups was 
significant with 67% of local anesthetic patients undergoing surgery compared 
to only 29% of corticosteroid plus anesthetic patients (p<0.004). Among 
patients with foraminal stenosis who avoided surgery, there was a significant 
decrease in neurological symptoms and low back pain on final evaluation. 
HIVD patients who avoided sugery showed a trend toward decreased back 
pain. 
 
 Ng et al 45 conducted a prospective RCT.  Of the 86 consecutively 
assigned patients included in the study, 43 were randomly assigned to receive 
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LTFESI (bupivacaine + corticosteroid) and 43 received injections of 
bupivacaine alone. Outcomes were assessed at three months using the VAS and 
ODI along with patient satisfaction and change in walking distance. Intent to 
treat analysis did not demonstrate a statistically significant difference in 
Oswestry scores between the two treatment groups.   In critique, this was a 
small study which was insufficiently powered to be an equivalence study. 
 
 Riew et al46  five year follow up prospective comparative study 
assessing the efficacy of nerve root blocks for the treatment of lumbar 
radiculopathy. Of the 29 consecutively assigned patients included in the study, 
eight were lost to final follow-up. They gave local anaesthetics  in one group  
and local anaesthetics with transforaminal steroid in another group. Majority of 
the patients who received steroid avoided surgery. They concluded that patients 
with lumbar radicular pain treated by means of transforaminal steroid therapy 
avoided  surgical intervention  for at least one year,  will continue to avoid 
operative intervention for a minimum of five years. This study clearly shows 
the therapeutic effect and cost effectiveness. Hence our patients also need long 
term follow up. 
 Bogduk N  et al47 performed a prospective randomized controlled trial 
(RCT) assessing the efficacy of lumbar transforaminal epidural steroid 
injection (LTFESI) for radicular pain secondary to disc herniation. Of the 150 
consecutively assigned patients included in the study, 28 received LTFESI with 
triamcinolone. Outcomes were assessed at one month and one year via the 
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Visual Analog Scale (VAS), SF-36 (version 1), Roland Morris Disability 
Questionnaire (RMDQ) and the Patient-Specified Functional Outcome 
instrument. Additionally work status and other health care services being 
utilized were assessed. The authors found that a significantly greater proportion 
of patients treated with transforaminal injection of steroid (54%) achieved pain 
relief compared to patients treated with transforaminal injection of local 
anesthetic (7%), transforaminal injection of saline (19%), intramuscular 
steroids (21%) or intramuscular saline (13%). Pain relief was corroborated by 
significant improvements in function and disability and reductions in use of 
other health care services. Outcomes were equivalent for patients with acute or 
chronic radicular pain. Over time, the number of patients who maintained relief 
diminished. Only some maintained relief beyond 12 months. In our study also 
we found relief diminishes over period of time.  
 Lee et al48 described a retrospective comparative study assessing the 
effectiveness of interlaminar, caudal and transforaminal techniques with small 
and large volume of injectate in the treatment of lumbosacral HIVD or spinal 
stenosis. Of the patients included in the study, 54 received caudal injections, 64 
received ILESI and 115 received LTFESI. Outcomes were assessed at two 
weeks, one month and two months using the VAS (Visual Analog pain Scale),   
Patient Satisfaction Index (PSI) and Roland Five Point Pain Scale. A higher 
ratio of successful results was found for translaminar and transforaminal 
techniques than caudal technique in VAS in the HIVD group and in VAS and 
PSI in the stenosis group. Reduction of Roland score was maintained until two 
88 
 
 
months in all techniques in the HIVD and stenosis groups. In the stenosis 
group, transforaminal groups showed more reduction of Roland score than 
caudal approach. No difference was found between small and large volume of 
transforaminal techniques. The authors concluded that the interlaminar and 
transforaminal approaches were more effective than the caudal approach for 
HIVD and stenosis groups. Effectiveness of the transforaminal approach was 
more prominent in the stenosis group as compared with the HIVD group. This 
study provides  evidence that LTFESI is significantly more often effective than 
fluoroscopically-guided caudal injections, but is not significantly more often 
effective than fluoroscopically-guided interlaminar injection. It provides  
evidence that LTFESI provides at least 50% relief at two months after 
treatment in 66% of patients with radicular pain due to disc herniations and in 
53% of patients with spinal stenosis. 
 
 Thomas et al49 performed a prospective RCT to determine the first-line 
injection procedure to recommend for treatment of lumbar radiculopathy 
secondary to a disc herniation. Of the 31 consecutively assigned patients 
included in the study, 15 were treated with LTFESI and 16 received blind 
ILESI. Patients were assessed at six months with the VAS, RMDQ and Dallas 
Pain Questionnaire. Compared to the ILESI group the LTFESI patients had 
statistically significantly greater improvement in VAS at 30 days and six 
months, and daily activities, work and leisure activities, anxiety and depression 
and RMDQ scores at six months. The authors concluded that the efficacy of 
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LTFESI is greater than ILESI for the relief of lumbar radicular pain at 30 days 
and six months 
 
 NASS (North American Spine Society) states  that presence of 
stenosis, size of HIVD, type of HIVD and hydration of HIVD do not predict 
outcome with LTFESI, but suggest that unsatisfactory results are statistically 
more likely in patients with higher grade herniation (displacement and 
entrapment of nerve root rather than abutment) and subarticular location of disc 
herniation.   
 
Our study and other studies provide evidence that  
1. LTFESI provides greater than 50% relief of pain in around 65% of 
patients for three months after treatment. 
2. LTFESI is significantly more often effective than ILESI.  
3. Relief of pain is associated with restoration of function and virtual 
elimination of the need for other health care. 
4. 48% of patients undergoing LTFESI have relief that persists for at least 
12 months, without repeat treatment;  
5. LTFESI substantially reduces the need for surgery.  
 
 Fluoroscopic transforaminal epidural steroid injections appear to be an 
effective nonsurgical treatment option for patients with degenerative lumbar 
scoliotic stenosis and radiculopathy and should be considered before surgical 
intervention. 
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 Fluoroscopy in TFESIs guides for precise delivery of the medication 
reliably to the interface between the HNP and the ventral aspect of the irritated 
nerve root.17  
 
 Without fluoroscopic guidance, there is a 30-40% chance of 
misplacing treatment into areas other than the epidural space at the site of 
herniation.28 Also, use of a blind technique to deliver the steroid depends 
on normal anatomy of the epidural space.  
 
 Modification of the approach around the abnormal anatomy to the 
exact site of irritation on the side of the symptoms is necessary for 
adequate administration of the steroid–anesthetic combination.  
 
 This modification and site directed treatment cannot be 
accomplished without the use of fluoroscopy. 
 
 The absence of complications such as dural   puncture and 
excessive bleeding commonly associated with blind epidural injection 
techniques attests to the safety of the fluoroscopic transforaminal 
approach.  
 
 Factors associated with the decreased success experienced by the 
steroid–anesthetic study group include development  spondylolisthesis,   
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further progression of disc herniation  and duration of symptoms 
exceeding 1 year.  
 The mechanical alteration of the disc–bone–nerve root interface 
in spondylolisthesis cannot be expected to change with the administration 
of epidural steroids. 
 The stretch of nerve root due to listhesis  combined with a large 
disc herniation probably led to the 0% success rate for these patients, 
although the sample size was very small (n-8 in group 1 and n-20 in 
group II) 
 Short term response to TFESI may also predict a favorable surgical 
outcome. 
 Also, the patients with symptoms duration exceeding 1 year had 
only a 50% success rate. Irreversible changes related to  chronic 
inflammation, including  irritation, may take place with chronic neural 
compression, perhaps rendering the nerve root refractory to management 
with the   local application of steroid.  
 The decreased success rate for patients with symptom duration 
exceeding 1 year may advocate for early initiation of transforaminal 
injection treatment. 
 
 ESI reduces economical burden for patients and health system. 
Also it  avoids unnecessary surgical burden for patient.   
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 From our study we found- Conservatively managed patients for a 
lumbar disc herniation  will improve.  
 
 It is described as 80% may improve in literature. The exact 
percentage may vary.    
 
 The less success rate for patients with symptom duration exceeding 
12 months advocates for early initiation of transforaminal injection 
treatment. 
 
 Even though Steroid effect detoriates over a time period in majority 
of patients due to progression of disease process, but significant number 
of patients have good response which lasts upto an year. 
 
 Pain relief effect  of steroid starts very early and lasts longer than 
disability improvement.  
 
 The sample size is small. Large sample size is needed.  
 
 Duration of study also short, long term follow up needed.  
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CONCLUSION 
 
From our study we conclude that  
1. Epidural steroid injections are safe without any major adverse effects. 
2. Patients with radicular pain from  disc herniation or lumbar canal 
stenosis obtain significant relief from a preganglionic LTFESI 
irrespective of age, gender, level of injection, symptom duration and 
pain intensity. 
3. Transforaminal epidural steroid therapy has better outcome with 
respect to   Roland Morris disability assessment,  Visual Numeric 
Scale, Finger Floor Distance assessment, Patient Satisfaction Score.   
4. Transforaminal steroid injection is superior to ILESI as it gives target 
specific administration.  
5. Interlaminar steroid administration is also useful if it is done under 
fluoroscopic guidance. But mostly   it is given blindly and hence the 
chances of the needle misplacement are there, so lesser success rate. 
6. Non responders rate is high in ILESI group. 
7. Transforaminal group disablity improves significantly. Maximum 
improvement occurs with in one month. Further improvement rate 
diminishes. In majority of the patients response lasts more than year.  
8. Patient Satisfaction and Pain Relief 
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                 -  majority of the patients have a significant improvement 
which lasts more than year. 
 
9. Lumbar transforaminal epidural steroid injections (LTFESI) are cost-
effective.  
 Transforaminal  epidural steroid treatment better medication for 
pain relief, patient satisfaction, disability improvement and functional 
improvement. 
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Annexure 
LIST OF  ABBREVIATIONS USED 
(In alphabetical order) 
    
CT  : Computed tomography  
ESI  :  Epidural steroid 
HNP  :           Herniated nuclosus pulposus 
HIVD :          Herniated intervertebral disc   
IFT  : Interferential Therapy  
IL        : Interlaminar  
ILESI  : Interlaminar epidural steroid  
IVDP  : Inter vertebral disc prolapse  
LDD    : lumbar disc disase  
LBA  : Low back ache 
LS   : Lumbo-Sacral 
LTEFSI     : Lumbar Transforaminal epidural steroid 
MRI  : Magnetic resonance imaging  
RCT  : Randomized control trial         
TFESI  : Transforaminal epidural steroid 
TF                  :  Transforaminal   
TENS  : Transcutaneous  Electric Nerve Stimulation  
 
  
 LIST OF TABLES 
 Table 1A  -  Head-to-head studies comparing  TFESI vs. ILESI 
 Table 1B  -  Head-to-head studies comparing TFESI vs. ILESI 
 Table 2      - Clinical nerve root syndrome 
 Table 3  -  Common Corticosteroids Used in Spinal Interventions 
Compared  with Hydrocortisone 
 Table 4  -   Frequency table for sex in each sub cohort 
 Table 5  - Descriptives mean and standard deviation 
 Table 6  - Descriptives   p value study 
 Table 7  - T-Test  study of standard error of mean. 
 Table 8  - Roland Morris Disability Mean Score  Analysis 
 Table 8A  - Roland Morris Disability Mean Score  Analysis in TFESI 
 Table 8B  - Roland Morris Disability Mean Score  Analysis in  ILESI  
 Table 9  - Independent Samples Test for descriptives 
 Table 10  - Case Processing Summary 
 Table 11  - Chi-Square Tests 
 Table 12  - Group Statistics 
 Table 13   - Independent Samples Test  
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1 SYED AHAMED 33 150/15 TFESI M 19 11 12 12 12 65 23 24 25 25 0 4 3 3 3 9 2 3 3 3 3 3 No 
2 PUNITHA 45 999035 TFESI F 17 10 11 11 12 67 21 23 25 25 0 3 3 3 2 8 3 3 3 3 4 4 No 
3 RAJENDRAN 46 53818 TFESI M 20 14 14 14 15 70 30 32 32 32 1 3 2 2 2 7 3 3 3 3 4 4 No 
4 AHAMED 25 20115 TFESI M 14 9 11 11 12 50 30 30 35 35 1 2 2 2 2 8 4 4 4 4 4 4 No 
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6 RAJA 52 100588 TFESI M 16 9 10 11 12 65 30 30 35 35 0 4 3 2 2 9 1 2 3 3 3 3 No 
7 AROKYA SAMY 47 90017 TFESI M 16 8 9 9 10 65 19 25 25 28 0 4 3 3 2 9 2 2 3 3 3 3 No 
8 ELANGOVAN 48 21768 TFESI M 17 9 10 10 11 67 19 23 23 28 1 4 3 2 2 8 2 2 3 3 3 3 Yes 
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16 BHARATHI 37 20215 TFESI F 18 14 15 16 17 70 60 60 65 70 0 1 1 1 1 9 8 8 8 8 8 9 Yes 
17 PITCHAI 52 20315 TFESI M 16 9 9 10 11 68 25 25 28 29 1 4 4 4 4 8 2 2 2 2 2 3 No 
18 SRINI 32 104190 TFESI M 16 13 13 14 15 65 55 55 59 59 0 2 1 1 1 8 5 6 6 6 7 8 Yes 
19 MAHARUNISHA 60 20415 TFESI F 18 16 16 17 18 70 65 65 65 69 1 1 1 1 1 9 8 8 8 9 9 9 Yes 
20 SYED BASHA 64 10804 TFESI M 13 8 8 8 9 55 25 25 26 27 0 4 3 3 3 8 2 2 2 2 2 3 No 
21 KUMAR 45 20415 TFESI M 17 11 11 12 12 65 32 32 35 37 1 4 4 4 4 9 1 1 1 1 1 2 No 
22 JANAKI 30 70399 TFESI F 19 12 13 14 15 80 45 46 47 47 0 4 3 3 3 9 2 2 2 2 3 3 No 
23 MUNUSAMY 51 118415 TFESI M 17 11 12 12 14 65 21 24 25 25 1 3 3 3 3 9 1 2 3 3 3 3 No 
24 MANOHAR 49 20515 TFESI M 12 6 6 7 7 40 15 16 18 19 0 4 4 3 3 8 3 3 3 3 3 3 Yes 
25 GANESH KUMAR 49 20615 TFESI M 16 9 9 10 10 57 19 23 23 23 0 4 3 3 2 9 1 4 4 4 4 4 No 
26 JANAKI 30 70399 TFESI F 15 12 12 13 14 65 45 47 57 65 0 1 1 4 4 9 8 8 8 8 8 9 Yes 
27 MANIARASU 51 20515 TFESI M 17 14 15 15 18 63 52 58 61 64 0 1 4 4 4 9 7 8 9 9 9 9 Yes 
28 VINOTHKUMAR 58 78596 TFESI M 19 11 12 12 13 56 21 22 22 28 0 3 3 3 3 8 2 2 2 3 3 3 No 
29 TAMILSELVAN 48 20615 TFESI M 14 8 8 11 12 45 24 25 25 35 0 3 3 2 1 8 3 3 3 3 3 4 No 
30 KAMALA 54 10815 TFESI F 16 9 9 10 11 52 29 30 30 30 0 4 4 4 3 9 2 2 2 2 2 2 No 
31 APPAN NAIDU 46 20715 TFESI M 19 13 14 15 16 68 41 43 45 47 0 2 2 2 1 9 3 4 4 4 4 4 No 
32 VADIVEL 43 84715 TFESI M 19 13 13 13 14 63 21 22 23 25 0 4 4 4 3 9 1 2 2 2 2 2 Yes 
33 JOHNSON 37 20815 TFESI M 16 13 13 14 15 52 39 41 45 50 0 2 2 2 2 8 4 4 4 4 5 8 Yes 
34 DHANALAKSHMI 39 95747 TFESI F 18 13 13 14 14 61 21 25 30 38 1 3 3 3 2 8 3 3 3 3 4 4 No 
35 RAJNI 42 20915 TFESI M 19 11 12 12 13 65 24 24 25 28 0 4 4 4 4 9 1 1 1 2 2 2 No 
36 NARAYANAN 39 40674 TFESI M 17 12 13 14 14 52 24 27 29 31 1 3 3 2 2 8 1 2 3 3 3 3 Yes 
37 THIRUMURUGAN 38 58875 TFESI M 15 12 14 15 15 54 40 45 48 55 0 2 1 0 0 9 7 8 8 9 9 9 Yes 
38 RAM BABUNISHA 40 87407 TFESI F 15 8 9 9 9 51 21 22 22 27 0 4 4 4 3 9 1 2 2 2 2 2 No 
39 KRISHNAN 26 96349 TFESI M 19 15 16 16 17 68 35 36 39 56 0 2 2 2 3 9 5 5 6 6 7 7 Yes 
40 SAKTHIMURUGAN 41 59325 TFESI M 13 8 9 9 9 45 21 23 24 25 1 4 4 4 3 8 2 2 2 2 3 3 No 
41 ABAIRAM 53 74787 TFESI M 19 11 11 12 12 68 21 23 23 25 0 4 4 4 3 9 1 1 2 2 2 2 No 
42 SARASWATHY 53 87253 TFESI F 20 17 17 18 19 69 51 53 59 68 0 2 1 1 0 9 6 7 7 8 9 9 Yes 
43 SHANTHA 55 73110 TFESI F 16 10 10 10 11 65 21 23 23 25 0 4 4 4 4 9 2 2 2 2 2 3 No 
44 ILAMARAN 28 66651 TFESI M 14 9 10 10 11 55 29 31 32 37 1 3 3 1 1 8 3 4 4 4 5 6 Yes 
45 AYYANAR 55 95289 TFESI M 17 13 14 15 17 69 55 59 65 68 0 2 1 0 0 9 5 8 9 9 9 9 Yes 
46 MURALI 40 103964 TFESI M 16 8 8 9 9 61 20 21 21 23 0 4 4 4 3 9 1 2 2 2 2 2 No 
47 VALLI 35 102036 TFESI F 17 11 11 12 12 69 19 20 21 23 0 4 4 4 4 9 2 2 2 2 3 3 No 
48 SELVI 39 46539 TFESI F 13 8 8 9 10 59 19 23 24 27 1 4 3 3 2 8 2 3 3 3 3 3 No 
49 MALAONDIAH 43 73298 TFESI M 15 9 11 12 14 67 45 54 55 65 0 2 1 1 1 9 5 6 8 8 9 9 Yes 
50 RAJA 46 22490 TFESI  15 11 12 12 14 69 42 55 59 64 0 1 1 1 0 9 6 7 9 9 9 9 Yes 
51 RENUKA 52 33346 ILESI F 17 13 13 14 15 65 41 43 46 49 0 2 2 2 2 8 3 3 3 3 3 4 No 
52 PACHAIPPAN 45 163/15 ILESI M 18 14 14 14 14 69 41 42 42 43 0 3 3 3 3 9 3 3 3 3 3 4 Yes 
53 PICHAIKANI 46 28529 ILESI M 15 10 10 10 11 55 30 31 32 32 1 3 3 3 3 8 3 3 3 3 4 4 Yes 
54 CHITRA 25 98257 ILESI F 16 11 12 12 12 61 29 29 31 33 0 3 3 3 2 8 3 3 3 3 4 4 No 
55 MUNIAPPAN 46 35637 ILESI M 17 14 15 16 17 63 52 55 59 63 0 1 1 1 0 9 6 7 8 9 9 9 Yes 
56 SARASWATHY 52 87253 ILESI F 18 13 13 13 13 65 30 31 31 31 0 3 3 3 3 9 2 2 2 2 3 3 No 
57 KALLANI 61 44550 ILESI F 17 12 12 12 12 63 31 31 31 31 0 4 3 3 3 8 2 2 2 2 2 3 No 
58 DURAIRAJ 48 48612 ILESI M 19 15 16 17 19 70 50 62 62 68 0 2 2 1 1 9 6 6 7 8 9 9 Yes 
59 RANI 34 100443 ILESI M 15 15 15 15 15 65 65 65 65 65 0 0 0 0 0 9 8 9 9 9 9 9 Yes 
60 SRINIVASAN 56 77888 ILESI M 17 11 11 11 11 65 25 25 25 25 0 4 4 4 4 9 2 2 2 2 2 2 No 
61 JEYA 45 42917 ILESI F 14 14 14 14 14 59 59 59 59 59 0 0 0 0 0 9 9 9 9 9 9 9 Yes 
62 BHARATHI 34 44086 ILESI F 17 15 15 15 15 68 58 58 58 58 0 2 1 1 1 9 5 6 6 6 6 7 Yes 
63 GANESAN 51 22346 ILESI M 17 12 12 12 12 60 28 28 28 28 0 3 3 3 3 8 2 2 2 2 2 2 No 
64 VIMALA 44 115868 ILESI F 16 15 15 15 15 60 58 58 58 60 0 1 0 0 0 9 7 8 9 9 9 9 Yes 
65 MANI 60 970 ILESI M 17 12 12 12 12 65 35 35 35 35 0 2 2 2 2 9 3 3 3 3 3 3 No 
66 JEGANATHAN 37 103493 ILESI M 16 13 13 13 13 68 45 47 47 47 0 2 2 2 2 9 4 4 4 4 4 4 Yes 
67 PARIMALA 31 48218 ILESI F 15 10 10 10 11 50 30 30 30 31 0 3 3 3 3 9 3 3 3 3 3 3 No 
68 RAJAMANICKAM 49 9648 ILESI M 17 16 17 17 19 69 65 68 69 69 0 1 0 0 0 9 8 9 9 9 9 9 Yes 
69 RAJU 21 19161 ILESI M 16 12 12 12 12 69 36 36 36 36 0 2 2 2 2 9 4 4 4 4 4 4 yes 
70 KRISHNAVENI 60 50930 ILESI F 14 14 14 14 14 68 68 68 68 68 0 0 0 0 0 9 9 9 9 9 9 9 Yes 
71 SELVARAJ 42 19147 ILESI M 16 11 12 12 12 59 30 30 31 32 0 4 3 3 3 9 3 3 3 3 3 3 No 
72 SRINVASAN 26 29972 ILESI M 17 16 17 17 17 65 63 65 65 65 0 1 0 0 0 9 7 9 9 9 9 9 Yes 
73 LAKSHMIBAI 55 114002 ILESI F 15 13 13 13 13 59 55 55 55 55 0 1 1 1 1 9 7 7 7 7 7 7 Yes 
74 JEYAMANI 43 110817 ILESI M 17 12 12 12 12 64 25 25 25 25 0 3 3 3 3 9 2 2 2 2 2 2 No 
75 SELVI 46 56428 ILESI F 19 14 14 14 15 69 35 35 37 37 0 3 3 3 3 9 2 2 3 3 3 3 No 
76 REVATHI 46 53877 ILESI F 15 15 15 15 16 56 56 56 56 58 0 0 0 0 0 9 9 9 9 9 9 9 Yes 
77 JEGANATHAN 24 103493 ILESI M 16 13 13 13 13 60 35 35 35 35 0 2 2 2 2 9 3 4 4 4 4 4 Yes 
 
 
78 SETHU 63 20815 ILESI M 19 15 15 15 15 70 39 39 40 40 0 3 3 3 2 9 2 2 2 2 3 3 No 
79 SASIKALA 23 54430 ILESI F 16 16 16 16 16 59 59 59 60 60 0 0 0 0 0 8 8 8 8 8 8 8 Yes 
80 BABY 45 67230 ILESI F 17 14 14 14 14 65 39 39 39 39 0 2 2 2 2 9 3 3 3 3 3 3 Yes 
81 MURUGESAN 55 55901 ILESI M 15 11 11 11 12 70 40 40 42 44 0 4 3 3 3 9 2 3 3 3 3 3 No 
82 MALARKODI 51 42802 ILESI F 13 10 10 10 10 51 23 23 23 23 0 2 2 2 2 9 4 4 4 4 4 4 Yes 
83 VASANTHA 45 77556 ILESI F 16 16 16 16 16 69 69 69 69 69 0 0 0 0 0 9 9 9 9 9 9 9 Yes 
84 RANGANATHAN 49 21015 ILESI M 17 14 14 14 14 65 51 51 52 52 0 1 1 1 1 9 7 7 7 7 7 7 Yes 
85 ARIVALAAGAN 56 21115 ILESI M 18 14 14 14 14 68 32 32 32 33 0 3 3 3 3 9 2 2 2 2 2 3 No 
86 PAPPA 50 103591 ILESI F 14 14 14 14 14 55 55 55 55 55 0 0 0 0 0 9 9 9 9 9 9 9 Yes 
87 PACHAIMUTHU 47 90917 ILESI M 18 15 15 15 15 69 45 45 45 45 0 2 2 2 2 9 4 4 4 4 4 4 Yes 
88 AROKYADOSS 61 20915 ILESI M 17 12 12 12 12 65 29 29 29 29 0 4 4 4 4 8 2 2 2 2 2 2 No 
89 GANDHIMATHY 47 20121 ILESI F 16 16 16 16 16 60 60 60 60 60 0 0 0 0 0 9 9 9 9 9 9 9 Yes 
90 JAMU 24 70228 ILESI M 15 12 12 12 12 55 39 39 39 39 0 2 2 2 2 9 4 4 4 4 4 4 Yes 
91 THANIGAI 56 21015 ILESI M 16 11 11 11 11 59 30 30 30 30 0 3 3 3 3 9 2 2 2 2 2 2 No 
92 RADHA 32 28377 ILESI F 14 14 14 14 14 65 65 65 65 65 0 0 0 0 0 9 9 9 9 9 9 9 Yes 
93 KARTHIK RAJA 23 78326 ILESI M 17 14 14 14 14 67 54 54 54 54 0 2 2 2 2 9 4 4 4 4 4 4 No 
94 VEERAMANI 31 55836 ILESI M 18 16 16 16 16 69 61 61 61 62 0 1 1 1 1 9 6 7 7 7 7 7 Yes 
95 KALIDOSS 30 22911 ILESI F 19 14 14 15 15 70 35 35 35 35 0 4 3 3 3 9 2 2 2 2 2 2 yes 
96 JEGAN 35 114201 ILESI M 17 15 15 15 15 70 55 55 55 55 0 2 2 2 2 9 4 4 4 4 4 4 Yes 
97 SANGEETHA 56 49436 ILESI F 17 11 11 11 11 70 25 25 25 25 0 3 3 3 3 9 2 2 2 2 2 2 yes 
98 ELUMALAI 37 48708 ILESI M 15 13 13 13 14 65 60 61 65 65 0 1 1 1 1 9 6 7 9 9 9 9 Yes 
99 INDRA 41 51502 ILESI M 16 16 16 16 16 62 62 62 62 62 0 0 0 0 0 8 8 8 8 8 8 8 No 
100 SRINIVASAN 42 24489 ILESI M 16 11 11 11 12 65 29 29 29 29 0 3 3 3 3 9 2 2 3 3 3 3 No 
 
INFORMATION SHEET 
 
Principle Investigator  Name : 
Participant Name : 
 We are conducting a study on COMPARATIVE STUDY OF 
FUNCTIONAL EFFICACY OF TRANS FORAMINAL VS INTERLAMINAR 
EPIDURAL STEROID INJECTION FOR LUMBAR DISC DISEASE”among 
patients attending the Institute of Orthopaedics & Traumatology, Rajiv Gandhi 
Government General Hospital, Chennai and for that your specimen may be valuable to 
us. 
           The purpose of this study is to evaluate and compare, the clinical,  and 
functional outcome of LUMBOSACRAL PAIN treated by transforaminal and 
interlaminar epidural steroid injection. We are selecting certain cases and if you are 
found eligible, we may be using your radiographs of the lumbo sacral spine  to 
document which in any way do not affect your final report or management.  
 All the procedures are free of cost and there will not be any side effects by 
using this plate. 
The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the research, no 
personally identifiable information will be shared. 
Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result in any 
loss of benefits to which you are otherwise entitled. 
The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
 
 
Signature of Investigator    Signature of Participant 
 
Date : 
Place : 
  
PATIENT CONSENT FORM 
 
Study Detail : “““COMPARATIVE STUDY OF FUNCTIONAL 
EFFICACY  OF TRANS FORAMINAL VS 
INTERLAMINAR EPIDURAL STEROID INJECTION 
FOR LUMBAR DISC DISEASE” 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
Identification 
Number 
:  
Patient may check (√) these boxes 
a) I confirm that I have understood the purpose of procedure for the above 
study. I have the opportunity to ask question and all my questions and 
doubts have been answered to my complete satisfaction.  
b) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason,  without my legal 
rights being affected. 
 
c) I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities 
will not need my permission to look at my health records, both in respect 
of current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study I agree to this access. 
However, I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required 
under the law. I agree not to restrict the use of any data or results that 
arise from this study. 
 
d) I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate with the 
study team and to immediately inform the study staff if I suffer from any 
deterioration in my health or well being or any unexpected or unusual 
symptoms. 
 
e) I hereby consent to participate in this study.  
f) I hereby give permission to undergo detailed clinical examination, 
Radiographs & blood investigations as required.  
 
 
 
Signature/thumb impression 
 
Patient’s Name and Address: 
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